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Hydrogen sulfide (H2S), regarded as the third gasotransmitter, plays diverse 
physiological and pathological roles in the body along with another two gasotransmitters, 
including nitric oxide (NO) and carbon monoxide (CO). In the liver, cystathionine gamma-
lyase (CSE) is the main enzyme to generate H2S. The functions of H2S in the liver are largely 
unknown even though many studies showed H2S and CSE are important in redox control of 
liver. S-sulfhydration, a novel post-translational modification of proteins, is now considered 
as an important mechanism of H2S effects under various physiological and pathological 
conditions.  
 Pyruvate carboxylase (PC), a mitochondrial enzyme, is an enzyme in the first step of 
gluconeogenesis in the liver. PC plays a critical role in tricarboxylic acid (TCA) cycle in 
mitochondria and in gluconeogenesis in the liver. PC is also involved in diverse metabolic 
pathways, such as lipogenesis and the biosynthesis of neurotransmitters. Here we found that 
H2S regulates gluconeogenesis through PC S-sulfhydration. First, PC activity and glucose 
production were decreased in liver of CSE-knockout (KO) mice comparing to the liver of 
wild type (WT) littermates. PC S-sulfhydration was lower in the liver tissue of CSE-KO mice 
than WT mice. NaHS which is commonly used for the H2S study as a H2S donor treatment 
induces glucose production and PC activity in the primary liver cells from mice. PC S-
sulfhydration was increased by NaHS treatment in a time–dependent manner. Through 
mutation study with site direct mutagenesis, we further confirmed that the cysteine residue 
265 is responsible for H2S S-sulfhdyration of PC. In cysteine 265 mutant-transfected 
HEK293 cells, PC activity was significantly decreased and PC S-sulfhydration was abolished. 
 Thioredoxin 1 (Trx1), a well-known redox protein, is reported to be involved in 
transnitrosylation and/or denitrosylation of proteins. Here we first demonstrated that Trx1 
acts as a S-desulfhydrase. Overexpressed Trx1 in HEK293 and HepG2 cells diminished H2S 
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induced S-sulfhydration of both glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
PC proteins. The S-desulfhydration activity of Trx1 was inhibited by PX12, an inhibitor of 
Trx1, and DNCB, an inhibitor of thioredoxin reductase. Furthermore, the cysteine 32 in Trx1 
is required for the direct interaction of Trx1 with GAPDH or PC, and mutation of cysteine 32 
abolished the S-desulfhydration activity of Trx1.  
 Taken together, our studies demonstrated that H2S induces the gluconeogenesis 
through PC S-sulfhydration, and Trx1 acts as a S-desulfhydrase. Our findings will help to 
understand the mechanisms of H2S regulation of metabolic pathways via S-sulfhydration. 
These understandings will also extend the knowledge of physiological and pathological roles 
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1. Hydrogen Sulfide (H2S) 
1. 1 Gasotransmitters 
 Gasotransmitter refers to a gaseous messenger molecule which is synthesized and 
released into the extracellular spaces to transit a series of signals and affect various cellular 
functions (1). The characterization of gasotransmitters has been clearly stated by Dr. Rui 
Wang (2) as: 1) small molecules of gas; 2) freely permeable to membranes; 3) endogenously 
and enzymetically generated and the generation is regulated; 4) well-defined specific 
functions at physiologically relevant concentrations; 5) mandatory to have specific cellular 
and molecular targets. The classification for gasotransmitters recently was updated including 
one more criteria as described below (3). 1) small molecule of gas, dissolved in biological 
milieu or not; 2) freely permeable to membrane not rely on cognate membrane receptors or 
other transportation machineries; 3) endogenously generated in mammalian cells with 
specific substrates and enzymes; 4) well-defined specific functions at physiologically relevant 
concentrations; 5) functions of endogenous gases can be mimicked by their exogenously 
applied counterparts; 6) specific cellular and molecular targets, and involved in signal 
transduction. 
 Gasotransmitters play important roles in various physiological and pathological 
condition, such as blood pressure regulation, neurotransmitter release, inflammation, cell 
growth and differentiation, and longevity, as reviewed in the article (4). Their unique roles 
have been received attentions since these simple inorganic compounds, such as hydrogen 
sulfide (H2S), nitric oxide (NO), and carbon monoxide (CO), act as important biological 
messengers in various cellular metabolisms and functions of vertebrates. After the 
identification of NO and CO as the first two gasotransmitters, the effects of H2S in 
physiological processes has been demonstrated and now H2S is well recognized as the third 
gasotransmitter (1, 3).  
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1. 2 H2S 
 H2S is a colorless, flammable, water-soluble gas with a strong odor of rotten eggs. 
This gas is generally produced by bacteria breakdown of waste material, and is found in 
volcanic gases and hot springs in nature, or contaminant from petroleum industry (5). Its 
toxicity has been known for more than 300 years in humans and animals (6). It is lethal in 
mammals above 1,000 ppm when inhaled, and it causes severe malfunctions when inhaled 
above safe levels, such as anxiety, irritation to eyes and respiratory tract, fatigue, and 
headache (2). 
 In spite of its toxicity, H2S has received attention as a physiological molecule since it 
is found in the body and plays a significant role in mammals. In cardiovascular system, H2S 
induced vasorelaxation was found in numerous types of blood vessels, such as aorta, portal 
vein, mesenteric artery, cerebral arteries, and vas deferens, from different species (rats, mice, 
cows, guinea pigs, sheep, and humans) (5). The vasorelaxant effect of H2S results from the 
modulation of KATP channel (7-10). In central nervous system, H2S also exerts multifaceted 
and important effects through the modulation of neurotransmitters, as reviewed in the article 
(5). Glutamate is an important neurotransmitter which is well known for its role in learning 
and memory in mammalian brain (11). It was found that H2S selectively enhances N-methyl-
D-aspartate (NMDA) receptor-mediated currents and expedites the induction of hippocampal 
long-term potentiation (LTP) in rats (12,13). In endocrine system, H2S-induced inhibition of 
insulin release was shown in INS-1E cells from a pancreatic insulinoma cell line (14) and in 
another insulin-secreting cell line, HIT-T15 (15) through the stimulation of KATP channels. 
Furthermore, diverse roles of H2S were found in various conditions of body, such as 
inflammation, cardiac protection, hypoxic damage, and etc (16). However, many things about 
the regulatory mechanisms of H2S on physiological roles in various tissues still remain 
unclear even though diverse roles of H2S were reported as described above. 
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1. 3 Biosynthesis of H2S 
 The biosynthesis of H2S in mammals occurs via enzymatic and non-enzymatic 
pathways (2). In enzymatic biosynthesis of H2S, it can be synthesized endogenously in 
mammalian tissues from L-cysteine by cystathionine beta-synthase (CBS), cystathionine 
gamma-lyase (CSE), and/or 3-mercaptosulfurtransferase (3-MST) (17). The expression of 
these enzymes is tissue specific. In some tissues, CBS, CSE and 3-MST are all needed for the 
generation of H2S, whereas in others, one enzyme suffices. H2S is synthesized mainly by 
CBS in the brain, whereas H2S is mostly generated by CSE in the liver, kidney, and vascular 
smooth muscles (2). In liver and kidney, 3-MST expression was higher than other tissues and 
3-MST is mainly localized in mitochondria (18). However, CSE is responsible for H2S 
production more than 3-MST in liver and kidney and 3-MST is expressed relatively more 
than CSE in other tissues (19). Based on its localization, 3-MST is responsible for the H2S 
production in mitochondria (20,21). Other sources of H2S is generated via non-enzymatic 
reduction of elemental sulfur, which is derived from the reducing equivalents of the oxidized 
glucose during glycolysis (22). H2S production through non-enzymatic reduction of 
elemental sulfur is minor in the cells compared to enzymatic production. The equation of H2S 
production in glycolysis is (22): 2C6H12O6 + 6S0 + 3H2O  3C3H6O6 + 6H2S + 3CO2   
 H2S production via non-enzymatic pathways is further described in 1. 3. 4 Non-
enzymatic synthesis of H2S. In gastrointestine, H2S can be uptaken from bacteria which can 
produce H2S. In the mucosa of the gut, cells and tissues are continuously exposed to H2S 
produced by sulfate-reducing bacteria, such as Desulfovibrio, Desulfomicro-bium, 
Desulfobulbus, Desulfobacter, Desulfomonas, and Desulfotomaculum genera (23). Patients 
with chronic fatigue syndrome (CFS) are shown with higher levels of H2S in intestine and 
higher concentrations of intestinal bacteria than normal (24). Abnormal chronic exposure of 
high concentration of H2S may be involved in the pathological effects in CFS. The healthy 
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microbiota is an important factor to regulate normal concentration of H2S in gastrointestine.   
 
1. 3. 1 CBS 
 CBS (EC 4.2.1.22) is a member of the beta family of pyridoxal phosphate-dependent 
enzyme to catalyze homocysteine to cystathionine in the first irreversible step of the 
transsulfuration pathway. Cystathionine is subsequently converted to cysteine, alpha-
ketobutryate, and H2S by CSE (Fig. 1. 1). CBS is composed with 551 amino acids and 
molecular weight of 63 kDa. The gene of CBS is located on chromosome 21 in humans or 17 
in mouse (25,26). The active form of CBS is a homotetramer and the enzyme activity is 
dependent on the heme group (protoporphyrim 1X). CBS is an essential enzyme for 
homocysteine metabolism in the cells (27). Human CBS deficiency, which is caused by 
inherited rare disorder, influences the homocysteine catabolism, and causes 
hyperhomocystinuria (28). Furthermore, CBS deficiency is associated with a wide range of 
clinical symptoms such as mental retardation, ectopia lentis, osteoporosis, skeletal 
abnormalities and hepatic steatosis (29). 
 
1. 3. 2 CSE 
 CSE (EC 4.4.1.1) is composed of 398 amino acids and the molecular weight is 43 
kDa, and CSE gene is located on chromosome 1 (2). CSE catalyzes cystathionine to cysteine, 
alpha-ketobutyrate, and ammonia in the second step of transsulfuration pathway (Fig. 1. 1). 
CSE then catalyses cysteine to H2S, ammonia, and pyruvate (30). CSE plays a critical role for 
supplying cysteine in various cellular functions (31,32). Cysteine is a necessary component 
for the synthesis of glutathione (GSH), a major intracellular antioxidant. CSE is critically 
involved in the biogenesis and regulation of GSH in physiological conditions (33-35). CSE is 
expressed in many tissues such as the cardiovascular system, respiratory system, liver, kidney, 
６ 
 
placenta, and pancreatic islets (7,36,37). Its expression is tissue-specific (2,5,12,38). In 
human, CSE deficiency is caused by autosomal recessive inheritance, which leads to 
cystathioninuria (39). The hypercystathioninemia triggers the development of atherosclerosis 
and cancer (40,41).  
 
1. 3. 3 3-MST 
 Recently, it was found that MST (EC 2.8.1.2) is involved in the H2S synthesis in the 
cells. 3-MST is located in both mitochondria and cytosol, while it mainly contributes to 
generate H2S in mitochondria (20,21). 3-MST catalyzes the sulfur transfer reactions from 3-
mercaptopyruvate (3-MP) to sulfite or other sulfur acceptors or forming elemental sulfur as 
shown in Fig 1. 1. Many studies on the physiological roles of 3-MST have been done in brain 
and neuron system (20,42,43). 3-MST was found in vascular endothelium of thoracic aorta 
and it plays an important role for the cellular bioenergenetic response in mitochondria (21,44). 
However, human deficiency of 3-MST is rare and it is not life-threatening (45).  
 
1. 3. 4 Non-enzymatic synthesis of H2S 
 Non-enzymatic synthesis of H2S is a minor source of total endogenous H2S 
generation in mammalian systems (2). H2S is generated from glucose, thiocystine, glutathione 
and thiosulfate in non-enzymatic synthesis as shown in Fig 1. 1 (46). Glucose and 
phosphogluconate can produce H2S via glycolysis and NADPH oxidase, respectively. In 
glycolysis, reducing equivalents of the glucose oxidation pathway mediates to reduce 
elemental sulfur to H2S. H2S is also generated through direct reduction of glutathione and 
thiocystine. Reductive reaction of thiosulfate can generate H2S from thiosulfate through the 




Figure 1. 1 Enzymatic and non-enzymatic synthesis of H2S (46). Cystathionine β-synthase 
(CBS), Cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (MST) are 
responsible for generating H2S in the mammalian systems. Through glucose, glutathione and 
polysulfides, non-enzymatic synthesis of H2S occurs under physiological condition.  
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1. 4 H2S metabolism  
 Endogenous H2S in the cells exists in various forms, such as free sulfide, acid-labile, 
and bound sulfide as cellular bioavailable pools. Cellular redox status or acidic pH may 
regulate the mobility of H2S from these pools for physiological responses (46). H2S is 
metabolized through expiration and excretion, methylation, scavenging, and oxidation in the 
body (Fig. 1. 2). Firstly, H2S can be metabolized into methanethiol and thiosulfate by 
bisulfide methyltransferase (BMT) and thiosulfate reductase (TSR) enzymes respectively as 
shown in Fig 1. 2. Produced thiosulfate is further oxidized to sulfite by thiosulfate 
sulfurtransferase (TSST) and subsequently to sulfate (46). Methanethiol can be methylated to 
dimethylsulfide. Alternately, H2S can be scavenged by methemoglobin or metallo- or 
disulfide-containing molecules such as oxidized glutathione (GSSG) (2,6,47). BMT and TSR 
are located in cytosol and periplasm, respectively. TSST is a mitochondrial enzyme. 
 It was recently found that sulfide-quinone reductase-like protein (SQRDL), the 
verterbrate homolog of sulfide-quinone oxidoreductase (SQR), contributes to  H2S 
metabolism in mammalian cells (48). SQR catalyses bisulfide (SH-) and quinine to 
polysulfide and quinol. SQR mediates in regulation of H2S levels in yeast (49). In various 
tissues in rats, it was found that SQRDL plays the same role as SQR in mitochondria (48). 
These researches showed the possibility that SQRDL can be responsible for the regulation of 




Figure 1. 2 Metabolism of H2S (46). H2S is metabolized into thiocyanate, methanethiol and 
thiosulfate catalyzed by rhodanese, bisulfide methyltransferase (BMT) and thiosulfate 
reductase (TSR) enzymes respectively. Thiosulfate can be further oxidized to sulfite through 
thiosulfate sulfurtransferase (TSST) and subsequently to sulfate. H2S reacts with hemoglobin 




1. 5 Pharmacological inhibitors of H2S producing enzymes  
 The development of pharmacological inhibitors of H2S producing enzymes and H2S 
releasing drugs are critical for the study of H2S effects on various physiological and 
pathophysiological events. Inhibitors for each H2S-generaing enzyme are shown in Table 1. 1. 
Propargylglycine (PPG), commonly used for a specific inhibitor of CSE, targets the pyridoxal 
phosphate binding site of CSE and irreversibly inhibits CSE activity. Aminoxyacetic acid 
(AOA) is an inhibitor for aminotransferase and is proposed as an inhibitor of CBS (50). To 
date, AOA and beta-cyanoalanine (BCA) are claimed as a selective inhibitor of CBS. 
However, it was shown that AOA and BCA can inhibit effectively CSE as well (51). 
Furthermore, it was found that BCA more selectively inhibits CSE than CBS and is a more 
potent inhibitor for CSE than PPG with a reversible inhibition (51). 3-mercaptopropionic acid 
is a non-competitive inhibitor of 3-MST. The specificity of these inhibitors are still 
questionable (5). 
 These pharmacological inhibitors of H2S-generating enzymes, including PPG, BCA, 
and AOA, have been employed to test the biological effect of inhibition of endogenous H2S 
production in several studies. PPG or BCA (50 mg per kg) in rats subjected to haemorrhagic 
shock accelerated the recovery of arterial blood pressure (52). In rodent models of local 
inflammation, PPG treatment (25-75 mg per kg) dose-dependently decreased paw oedema 
and paw neutrophil infiltration in a carrageenan-induced inflammation model of rat (53), and 
PPG (100 mg per kg) attenuated pancreatic necrosis and reduced the degree of acute lung 
injury in a cerulean model of pancreatitis (54). Furthermore, it was recently found that AOA 
treatment (0.2 mM, daily) inhibits colon cancer growth in patient-derived tumor xenografts 





1. 6 H2S releasing drugs (donors) 
NaHS and Na2S are two well-used H2S donor. NaHS and Na2S are convenient to 
handle, however they are not appropriate for the study of long term exposure since H2S are 
easily evaporated and H2S is released immediately from NaHS and Na2S in biological media. 
Within 2 hours, H2S is not able to be detected in biological media treated by NaHS and Na2S 
(56,57). Nowadays, many H2S releasing drugs are developed for investigating the 
physiological effects of H2S. Those are convenient for controlling the concentration of H2S in 
biological media and H2S releasing can be lasted longer compared with NaHS and Na2S (57-
62). Sustaining H2S concentration in culture medium is observed when incubation of the cells 
with GYY4137 (400 µM) from 2 hours to 7 days (57). Other slow-releasing H2S drugs 
similar to GYY4137 include S-diclofenac (ACS15 and ACS32), S-sildenafil (ACS6), S-
latanoprost (ACS67), and S-mesalamine. These drugs are produced from combination of 
parent compound (drug chemical) and 5-(4-hydroxyphenyl)-3H-1,2-dithiol-3-thione (ADT-
OH), which in turn break down to H2S (38). The moiety of ADT-OH is the most widely used 
for synthesizing slow-releasing H2S drugs and H2S releasing drugs are included the moieties 
of H2S donor similar to ADT-OH.  
 GYY4137 and ATB346 (the derivate of naproxen) as well as ACS32 (derivate of S-
diclofenac) induced cell death of several cancer cell lines but not in normal cells (57,63,64). 
GYY4137 and ATB346 further exhibit anti-inflammation activity along with ACS85 and 
ACS86, which are derivates of levadopa (65-71). Cardiovascular protection effects of 
Thioamide, perthiols, and GYY4137 were further found (72-74). Rhodanine derivates 
showed anti-virus and anti-microbial activity (75-77). Furthermore, GYY4137 regulates ion 
channels similar to H2S roles as an opener of ion channel proteins (78,79). The list and 
functions of H2S releasing drugs are shown in Table 1. 2. 
 Recently, functional H2S releasing donors are under investigation. General H2S 
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donors are lacked to mimic the slow and continuous H2S generation process in vivo. Cysteine 
activated H2S donors, as a controllable H2S donor, which can produce H2S in presence of 
excess cysteine were developed (73, 74, 80). H2S releasing from donors can be regulated by 
the cysteine concentration. However, further biological data will be required to evaluate the 
pharmacological functions of donors. For the study of H2S releasing donors, cytotoxicity of 
donors is critical in the cell. H2S releasing donors based on ADT-OH induced cellular 
trafficking of ADT-OH and then toxic to the cells. To prevent the cytotoxicity of H2S 
releasing donors based on ADT-OH, a poly (ethylene glycol)-ADT was developed (81). It 
was successfully to release H2S in macrophages and was not shown obvious cytotoxicity 
compared to H2S releasing donors based on ADT-OH. Furthermore, mitochondrially-targeted 
H2S releasing donor, AP39, [(10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5yl)phenoxy)decyl) 
triphenylphosphonium bromide], was developed and investigated the effects of AP39 on 
bioenergetics, viability, and mitochondrial DNA integrity (82). The control of H2S releasing 





Table 1. 2 H2S releasing drugs 
Donor Effect Reference 
GYY4137 
Ion channel regulation (78,79) 









Reduce toxicity and anti-inflammation (65,66) 
Anti-nociceptive and anti-inflammation (67) 
ACS32 Anti-cancer (63) 
ACS85 and ACS86 Nervous protection and anti-inflammation (68,69) 
Thioamide Cardiovascular protection (73) 




1. 7 Liver 
   
1. 7. 1 Gluconeogenesis in liver 
 Glucose metabolism is a critical biochemical process in liver since glucose is an 
energy source in mammalian systems. Especially, liver regulates glucose level through 
gluconeogenesis. Insulin inhibits gluconeogenesis in the liver, while glucagon and 
glucocorticoid induce gluconeogensis to produce glucose. 
 Gluconeogenesis is a metabolic pathway that generates glucose from non-
carbohydrate carbon substrates such as pyruvate, lactate, glycerol, and glucogenic amino 
acids. When the glucose level drops (hypoglycemia) in blood, there are two ways for 
supplying glucose including degradation of glycogen via glycogenolysis and gluconeogenesis 
from non-carbohydrate carbon source. In animals, gluconeogenesis takes place mainly in the 
liver and cortex of kidneys. Targeting gluconeogenesis is an efficient strategy for the therapy 
of type 2 diabetes. Metformin, an antidiabetic drug, is well known for the inhibition of 
glucose formation and stimulation of glucose uptake by cells (89).  
 Gluconeogenesis is regulated by a series of enzymes (Fig. 1. 3). Depending on the 
substrates, gluconeogensis occurs in the mitochondria from pyruvate or from glycerol in the 
cytoplasm. In the mitochondria, pyruvate carboxylase (PC) catalyzes pyruvate into 
oxaloacetate. Oxaloacetate is reduced to malate for its transportation to cytosol. Malate is 
oxidized to oxaloacete in the cystosol for remaining steps of gluconeogenesis. In 
gluconeogenesis, oxaloacetate is decarboxylated and then phosphorylated to 
phosphoenolpyruvate by phosphoenolpyruvate carboxykinase (PEPCK). The next steps are 
the reverse direction of glycolysis from phosphoenolpyruvate to glucose.   
 PC is a key enzyme in the control of gluconeogenesis. Most factors which are 
involved in the regulation of gluconeogenesis act through modification of activity or 
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expression of PC. Aacetyl CoA and citrate activate PC, respectively (90). Global control of 
gluconeogenesis is mediated by hormones. Those hormones are actually regulated by blood 
glucose level. When blood glucose is low, glucagon and glucocorticoid are released from 
pancreas and zona fasciculate of the adrenal cortex, respectively. Once glucagon is released 
from pancreas, glucagon binds to the glucagon receptors in liver cells. Liver cells then 
produce glucose through promotion of gluconeogenesis and glycogenolysis. Glucagon turns 
off glycolysis and provides the glycolytic intermediates to gluconeogenesis in order to 
synthesize glucose. Also, glucocorticoid stimulates gluconeogenesis in the liver. 
Glucocorticoid binds to glucocorticoid receptors in the liver and then induces the synthesis of 
glucose from non-hexose substrates, such as amino acids and glycerol, in gluconeogenesis. 
Insulin is produced by pancreas when blood glucose is high. Insulin increases glucose uptake 
in muscle, adipose and several tissues and glycogen synthesis for storage of glucose in liver 
and muscle cells. In addition, insulin decreases gluconeogenesis for preventing further 
glucose production from non-hexose (91,92).  
Gluconeogenesis is associated with metabolic syndromes, such as diabetes, obesity, 
etc. Metabolic syndrome is clinically defined by the National Cholesterol Education Program 
(NCEP) as any three of the following five traits: abdominal obesity, impaired fasting glucose 
(reflecting insulin resistance), hypertension, hypertriglyceridemia, and low HDL cholesterol 
(93). Obesity initiates metabolic syndrome through increase of lipogenesis and 
gluconeogenesis with insulin resistance (93). Increased abdominal fat mass induces the 
accumulation of intracellular fatty acids and its metabolites (fatty acyl CoA, diacylglyceride), 
causing insulin resistance. Insulin resistance induces gluconeogenesis to stimulate plasma 
glucose content. Increased glucose and insulin raises lipogenesis which enhances adipocyte 
insulin resistance. Gluconeogenesis is critically involved in the development of metabolic 




1. 7. 2 The roles of H2S in liver 
 CSE is a main enzyme to generate H2S in the liver. Deficiency of CSE gene 
diminished H2S production by more than 90% in mouse liver (37,94). H2S affects diverse 
metabolisms which take place in the liver, such as lipid, glucose, and bioenegetic metabolism 
(95). Lipid metabolism is critically associated to cholesterol and low density lipoprotein 
(LDL) cholesterol. In previous study, it has been found that CSE knockout (KO) mice on 
atherogenic diet showed increased plasma total cholesterol and LDL cholesterol levels and 
decreased HDL cholesterol compared to wild type (WT) mice (96). It was also reported that 
H2S is directly involved in the lipid metabolism (97). H2S significantly impaired basal and 
insulin-stimulated glucose uptake and glycogen storage, and enhanced gluconeogenesis and 
glycogenolysis (98). H2S induced by MST in the mitochondria of murine hepatoma cell line 
Hepa1c1c7 enhanced mitochondrial electron transport and cellular bioenergetics (99). Altered 
hepatic H2S generation and metabolism have been demonstrated to be involved in the 
pathogenesis of many liver diseases, such as ischemia/reperfusion injury, hepatic fibrosis and 
cirrhosis (100-103). Furthermore, H2S is involved in hepatoprotection. H2S attenuates hepatic 
ischemia-reperfusion injury through preservation of intracellular redox balance and by 
inhibition of apoptosis in the ischemia-reperfusion injury (104).  
 
2. Pyruvate Carboxylase (PC) 
 PC (EC6.4.1.1) is a nuclear encoded mitochondrial enzyme that catalyses pyruvate 
into oxaloacetate (105). PC was first discovered in 1959 and isolated from chicken liver (106). 
In mammals, PC plays a crucial role in gluconeogenesis and lipogenesis, in the biosynthesis 
of neurotransmitters, and in glucose-induced insulin secretion by pancreatic islets (107). PC 
is highly expressed in the liver, kidney, adipose, and pancreatic islets (108). The pyruvate 




Figure 1. 4 The overall pyruvate carboxylation reaction by PC (109). 
 
PC is an important metabolic enzyme, and its expression is regulated in different 
pathphysiological conditions, including nutritional alterations, diabetes, hormonal changes, 
and neonatal development (110). PC activity and expression have been shown to be induced 
in fasting animals (91,111-113). Hormonal alterations affect PC activity and expression. 
Hepatic PC activity was increased in hyperthyroid rats, whereas in hypothyroid rats PC was 
decreased (114). Furthermore, hormonal regulation is involved in the increase of PC activity 
and expression in fasting through glucagon and glucocorticoids (92). It has been recently 
found that PC plays an important role in insulin release of pancreatic β-cells in obesity and 
type II diabetes (115,116), and is involved in the development of insulin resistance in mice 
(117). PC expression was elevated in genetically obese Zucker fatty rats (118). In humans, 
PC deficiency is an autosomal, recessively inherited disease (110). PC deficiency leads to 
congenital lactic acidosis and deterioration of the central nervous system (119,120). In mild 
PC deficiency, patients suffer from mild-to-moderate lactic acidaemia, delayed development 
and psychomotor retardation. Patients in severe PC deficiency exhibit severe lactic acidaemia 
with hyperammonaemia, citrullinaemia, and hyperlysinaemia, and they rarely survive longer 
than 3 months after birth (110).  
 PC activity was reduced in the islets of animal models of type 2 diabetes and is a 
critical factor for the beta cell adaptation to insulin resistance in the rat (121). Furthermore, it 
was found that decreased PC activity in islet is related to the development of type 2 diabetes 
in Agouti-K mice (122). In pancreas, reduced PC activity is a pathological factor for the 
development of type 2 diabetes. However, recent study showed that tissue-specific inhibition 
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of PC is a potential therapeutic approach for hepatic insulin resistance and type 2 diabetes 
(116). Specific antisenese oligonucleotide (ASO) for PC decreases PC expression in liver and 
adipose tissue in rats. Decreased PC activity by ASO reduces gluconeogenesis in liver and 
improved heaptic insulin sensitivity. Therefore, PC will be a promising therapeutic target for 
type 2 diabetes and insulin resistance through the regulation of PC activity in tissue-specific 
manner, for example, PC activity is induced in pancreas and reduced in liver.  
 
2. 1 Regulation and modification of PC 
 Fasting or starvation enhances glucose production in liver sustained by an increased 
pyruvate flux through increases of PC activity and expression (123). Transcriptional 
regulation of PC gene is extensively studied. The distal promoter of the rat PC gene is active 
in pancreatic islets but the proximal promoter is active in gluconegenic and lipogenic tissue 
(Fig. 1.5) (107). The basal transcription activity of PC is regulated by Sp1/Sp3 and NF-Y in 
the distal promoter. Pancreatic specific promoters, such as forkhead transcription factor 
boxA2 (Foxa2/HNF3beta), upstream stimulatory factors (USF1 and USF2), PDX1, and v-
Mafa, are found in pancreatic cells and tissues through analysis of PC gene promoters and 
identification of its functions in PC regulation (107). In the proximal promoter, Peroxisome 
proliferator-activated receptor (PPAR) gamma1 and PPARgamma2 are involved in the 
transcriptional regulation of PC in the adipose tissues. cAMP-responsive element binding 
protein (CREB) is found to be involved in the regulation of proximal promoter of PC in the 
liver. PC expression is increased in rodent models of type 1 diabetes which is induced by 
streptozotocin (124,125) and obese Zucker diabetic fatty rats (126). The proximal promoter in 
the liver and adipocytes is involved in the increase of PC expression in diabetes, not the distal 
promoter. Islet PC expression is decreased in severe type 2 diabetic Agouti-K mice and 
human patients with type 2 diabetes (122,127). The different PC expression among liver, 
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adipocytes, and pancreas in diabetic conditions results from the different transcriptional 
regulation of PC by proximal and distal promoter. The detail regulatory mechanisms of PC 
expression in diabetic conditions are not clearly determined yet. However, these regulations 
may be related to the development of diabetes and dysfunction of glucose homeostasis in the 
body. For the regulation of PC activity, the allosteric regulation is one of the important 
factors. Acetyl CoA is a well known allosteric activator of PC. In some bacteria, such as 
Mycobacterium smegmatis and  Rhodobacter capsulatus, PC activity exhibits a nearly 
absolute requirement for acetyl CoA while mammalian PC activity is retained between 2 % 
and 30 % of maximal activity in the absence of acetyl CoA (109). PC activity is dependent on 
the concentration of Acetyl CoA. Acetyl CoA cooperates with Mg2+, which is an allosteric 
activator. In yeast PC, it was shown that acetyl CoA and K+ are the enzyme activator and 
cysteine 249 in yeast PC is involved in the regulation of binding and action of acetyl CoA and 
K+ to active site of PC (128).  
 Catalytic activity of PC is dependent on the presence of pyruvate, HCO3-, and 
MgATP along with acetyl Co-A and Mg2+, as described above (106). Pyuvate is related to the 
PC activity, as a main substrate. PC catalytic carboxylation of pyruvate is composed of two 
steps in distinct active sites (110,129). These two partial reactions occurs in biotin 
carboxylase (BC) domain and carboxyl transferase (CT) domain. HCO3-, and MgATP, except 
for pyruvate and Acetyl-CoA, are mainly involved in the catalytic reaction of BC domain 
which is the first partial step of catalytic reaction of PC. HCO3- is the substrate in the first 
partial step of pyruvate carboxylation. MgATP is necessary for the pyruvate carboxylation 
and acts as a cofactor. Especially, the activation of HCO3- is dependent on MgATP. The use of 
MgATP is required for the diminished electrophilicity of HCO3- to form the highly labile 
carboxylphosphate intermediate via the nucleophilic attack of HCO3- on the gamma-
phosphate of ATP. However, MgATP-dependent carboxylation did not occur through the 
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formation of a phophorylated-enzyme intermediate (130). Every intermediate is prepared in 
the first partial step of pyruvate carboxylation. In CT domain, the second step is occurred that 
pyruvate reacts with CO2 to form oxaloacetate.   
 The post-translational modification on PC has not been well-studied as compared to 
the PC transcription regulation by hormone. S-nitrosylation of PC has been observed in yeast 






Figure 1. 5 The promoter of PC in mammalian tissues (107). The PC gene is regulated by 
two alternative promoters, the proximal (P1) and the distal (P2). P1 promoter mainly is active 
and responsible for the expression of PC in adipose and gluconeogenic tissue. P2 is a main 




3. Post-translational modification of proteins (PTM) 
 Post-translational modification is a common mechanism for regulating the activity of 
proteins. There are many factors involved in protein post-translational modification, such as 
phosphate, acetate, methane, various lipids and carbohydrates.  
 
3. 1 Phosphorylation 
 Phosphorylation is the addition of a phosphate group to a protein. Phosphorylation 
plays a significant role in a wide range of cellular processes, and a large number of proteins 
can be regulated by phosphorylation. Phosphorylation occurs with the aid of kinases, which 
transfers phosphate from ATP to the target proteins. The specificity of kinases ranges broadly. 
The commonly occurring sites of phosphorylation in proteins are on the serine, threonine, 
and/or tyrosine residue (133,134). Phosphorylation is regulated by kinases, which 
phosphorylate proteins. In many enzymes and receptors, phosphorylation and 
dephosphorylation play a regulator of enzymes and receptors, as a switch-on and off of 
enzyme activity (135). Those regulatory mechanisms resulted from a conformational change 
in the structure of enzymes and receptors. ATP is required for the phosphorylation as a donor 
of phosphate. Kinases transfer one of phosphoryl groups of ATP to a specific amino acid as 
described above. Phosphatases reverse the effects of kinases by catalyzing the removal of 
phosphate from phosphorylated protein.  Antibodies for recognizing phosphorylated proteins 
are powerful tools for the detection of protein phosphorylation. These antibodies can detect 
phosphorylation-induced conformational changes in proteins based on the addition of 
phosphate in target site, called phospho-specific antibodies. Hundreds of phospho-specific 





3. 2 Acetylation 
 Protein acetylation is an important modification of proteins which consists of N-
terminal acetylation and lysine acetylation. N-terminal acetylation is a common co-
translational covalent modification of proteins which occurrs concurrently with its mRNA 
translation by N-terminal acetyltransferases. N-terminal acetylation plays a critical role in the 
synthesis, stability and localization of proteins (136,137). Lysine acetylation occurs in lystine 
residues in proteins as a post-translational modification. Acetyl-coenzyme A is an important 
factor for lysine acetylation, as the acetyl group donor. Lysine acetylation is important for the 
histone acetylation and deacetylation to regulate gene expression. These reactions are 
regulated by histone acetyltransferase (HAT) and histone deacetylase (HDAC). The 
regulatory mechanism of lysine acetylation is analogous to phosphorylation and 
dephosphorylation by kinases and phosphatases.  
 Lysine acetylation is an important regulation of transcription factors, such as effector 
proteins and molecular chaperones for the gene regulation. Furthermore, histone acetylation 
and deacetylation are critical targets for the transcriptional regulation in the epigenetics. The 
detection of protein acetylation relies on acetylation antibodies. These antibodies can detect a 
conformational change by acetyl group on the specific amino acid residue from the acetylated 
proteins.  
 
3. 3 Methylation 
 Protein methylation typically occurs in arginine or lysine amino acid residues in 
proteins (137). Arginine can be methylated for one or two times on terminal nitrogens by 
peptidylarginine methyltransferases (PRMTs) and lysine can be methylated up to three times 
by lysine methylatransferases. Protein methylation is commonly studied in the histones which 
methylation is occurred by histone methyltransferases. Histone methyltransferases transfer 
２６ 
 
methyl groups from S-adenosyl methionine to histones. Methylated histone by histone 
methyltransferases act epigenetically to repress or activate gene expression (138). The 
detection methods for protein methylation also rely on the specific methylated antibodies 
similar to protein acetylation. 
 
3. 4 Cysteine modifications: S-nirosylation, S-sulfhydration, S-glutathionylation, and 
sulfenylation 
 Cysteine and methionine are two sulfur-containing amino acids in protein. 
Methionine does not have a catalytic role because sulfur in methionine possesses high 
stability compared to sulfhydryl (thiol) group in cysteine (139). Cysteine possesses a free 
thiol side chain which is nucleophilic, acidic (pKa ~8) and redox active (140). Thiol side 
chain in cysteine plays important roles for regulating protein structure and function through 
the formation of disulfide bond or interactions with metal ions, such as zinc, copper, and iron 
in proteins (141,142). High reactivity of cysteine in proteins is essential for the function of 
proteins. Cysteine modification in proteins is critical for regulation of protein activity, 
including S-nitrosylation, S-sulfhydration, S-glutathionylation, and sulfenylation (143).  
 
3. 4. 1 S-nitrosylation 
 S-nitrosylation is a well known mechanism for NO-based signaling, which is the 
covalent incorporation of a NO moiety into thiol group of cysteine to form S-nitrosothiol (S-
NO) in the targeted protein. Many factors are essential for the formation of S-nitrosylation, 
including i) the acid-base motif in 3D structure of proteins i.e, cysteine residue is located 
between aspartic acid (acid) and histidine (base); ii) nucleo-philicity (pKa) of target cysteine 
residue; and iii) presence of different metal ions, such as Mg2+ or Ca2+ (144).  
 It is predicted that S-nitrosylation influences protein functions through 
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conformational change (144). A large number of studies have reported that S-nitrosylation is 
involved in diverse regulations, such as epigenetics, transcription, metabolism, and the 
activities of membrane-associated proteins, and so on (145). During neuronal development, 
nNOS induced S-nitrosylation of histone deacetylase 2 (HDAC2) leading to its dissociation 
from chromatin (146). S-nitrosylation of HDAC2 promotes chromatin remodeling and the 
activation of genes which are associated with neuronal development. S-nitrosylation of 
HDAC2 is essential for the neuronal development. S-nitrosylation-induced activation of 
glucokinase and inhibition of insulin receptor contribute to metabolic changes in pancreatic 
beta-cells (147,148). The activities of membrane-associated proteins, such as ion channels, 
are also regulated by S-nitrosylation (145). L-type Ca2+ channels are inhibited by S-
nitrosylation in smooth muscle cells and K+ and Ca2+ channels are modified by S-
nitrosylation in the heart (145,149). S-nitrosylation influences NMDA receptor which are 
associated with ion channels(150). In mutated NMDA receptor in cysteine 399 on the NR2A 
subunit, S-nitrosylation was deleted and the regulation of ion channels by NMDA receptor 
was not modulated by endogenous NO.  
 The studies for the forming mechanism of protein S-nitrosylation are commonly 
focusing on searching the consensus motifs from the linear sequence of amino acids. Based 
on the analysis of NO transfer in hemoglobin, the acid-base motif was suggested as a concept 
for S-nitrosylation in linear sequence of amino acids (151). In the report by Ascenzi and 
colleagues (152), the acid-base motif has been advanced in the three-dimensional (3D) 
structure basis in order to elucidate the concept for S-nitrosylation and denitrosylation. It was 
suggested that the mechanism of protein S-nitrosylation is dependent on its 3D structure, but 
not on linear sequence of amino acids in the protein. Therefore, acid-base motif may be a 
docking site of NO donor for protein S-nitrosylation and donor molecules of NO are 
necessary to form protein S-nitrosylation in acid-base motif. The proposed forms of NO 
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donor molecules for protein S-nitrosylation are nitrosothiols (RSNO). Nitrosoglutathione 
(GSNO) is a well known endogenous RSNO which is critically involved in NO signaling and 
acts as a pool of NO in the cells. Endogenous GSNO is regulated by GSNO reductase 
(GSNOR) and GSNOR is involved in the controlling protein S-nitrosylation (153,154). 
However, GSNOR is not directly related to the regulation of protein S-nitrosylation. The 
regulation of protein S-nitrosylation by GSNOR is in the indirect regulation of protein S-
nitrosylation through the controlling of GSNO levels in the cells. Along with GSNO, another 
bioavailable source of NO is a nitrosocysteine (CSNO). CSNO is often employed as a donor 
of NO for protein S-nitrosylation (155-157). Since some cases of protein S-nitrosylation were 
found not followed with the acid-base motif, the acid-base motif for the forming mechanism 
of S-nitrosylation is lacked to explain all the cases of protein S-nitrosylation (158). Marino 
and Gladyshev suggested that these exceptional cases were explained with protein-protein 
interaction and direct interaction by NO to form protein S-nitrosylation. In these cases, S-
nitrosylated cysteine residues in 3D structure of protein are available to directly bind with 
other proteins and NO. Diverse forming mechanisms of protein S-nitrosylation may be 
existed (158). 
 For the detection of S-nitrosylation, NO-based strategies are mainly considered for 
either the direct NO detection or NO switched manner. The sulfur-nitrogen bond in SNO is 
particularly labile, and the lability of NO in SNO is an important factor for the detection of S-
nitrosylation. Based on this concept, many methods were developed for detection of S-
nitrosylation. Biotin switch assay (BSA) is often used for the detection of protein S-
nitrosylation (159). The overview of BSA procedure is as follow. First, free thiol groups in 
proteins are blocked with thiol-specific methylthiolating agent, methyl methanethiosulfonate 
(MMTS). NO in SNO is decomposed and reduced to free thiol with ascorbate, and then 
labeled with a thiol-specific biotinylating reagent. Total S-nitrosylated proteins can be 
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detected with anti-biotin antibody by immunoblotting. To detect specific protein which is S-
nitrosylated, biotinylated proteins were purified with avidin conjugated beads and then 
immunoblotted with specific antibody to visualize specific S-nitrosylated protein for analysis. 
 
3. 4. 2 S-sulfhydration 
 S-sulfhydration, which is a novel post-translational modification of cysteine residues 
in proteins, is similar to S-nitrosylation. H2S interacts with the free thiol group and forms a 
hydropersulfide group (-SSH) in the target proteins. It is predicted that H2S posttranslational 
modification of protein through S-sulfhdyration mediates most of H2S bioactivity in the body. 
H2S acts as an endothelium-derived hyperpolarizing factor through the S-sulfhydration of 
potassium channels (160). S-sulfhydration of Keap1 activates Nrf2 and protects against 
cellular senescence (34). S-sulfhydration MEK1 leads to PARP activation and improves DNA 
damage repair (161).  
 The regulatory mechanisms of protein S-sulfhydration are relatively unknown 
compared to the regulatory mechanisms of protein S-nitrosylation. The regulation of protein 
S-sulfhydration by GSSH was suggested (162). It was found that the abundant quantities of 
GSSH and H2S are related to protein S-sulfhydration and transsulfuration reactions when 
compared in plasma, brain, and liver.  The concentration of GSSH in tissues was in direct 
proportion to the concentration of H2S. Furthermore, the concentration of GSSH was related 
to the increase of protein S-sulfhydration in the tissues, like a GSNO in protein S-
nitrosylation. Similar to GSNOR in degradation of GSNO in the cells, a mitochondrial 
persulfide dioxygenase enzyme, ETHE1, mediates degradation of GSSH (162,163). ETHE1 
indirectly governs protein S-sulfhydration through the controlling of GSSH, like a GSNOR in 
protein S-nitrosylation. Therefore, acid-base motif might be a potential concept for the 




 At present, BSA is employed as a main technique to determine S-sulfhydrated 
proteins. The difference between BSA detection of S-sulfhydration and S-nitrosylation is in 
the first step, where deferoxamine is used to reduce SNO to free thiol and then all free thiols 
are blocked by MMTS. The procedures of BSA for protein S-sulfhydration and S-




3. 4. 3 S-glutathionylation 
 S-glutathionylation, a reversible modification of cysteine residues, is formed by a 
reaction of oxidized glutathione (GSSG) with free thiol. S-nitrosylated thiol is one of the 
possible intermediates for S-glutathionylation (143). S-glutathionylation of proteins are 
involved in the various diseases such as diabetes, cardiovascular disease, and 
neurodegenerative diseases (164). Aldose reductase (AR) plays an important role in glucose 
metabolism to provide sorbitol for the synthesis of fructose, which is associated with diabetes. 
S-glutathionylation of AR at cysteine 298 inhibits its activity with normal glucose 
concentration (165). Ryanodine receptors (RyR) regulate calcium release from the 
endoplasmic reticulum into the cystosol which is an important subject for pathological 
implications, including diabetes, cardiovascular complications, and Alzheimer’s disease (164). 
S-glutathionylation of RyR1 at cysteine 3635 is involved in calcium release and RyR1 is 
critically regulated by S-glutathionylation along with S-nitrosylation at same cysteine residue 
(166). Furthermore, S-glutathionylation was found in various proteins which are related to 
signal transduction in the cells, such as Ras, MAPK/ERK kinase kinase (MEKK), c-Jun, Akt, 
IkB kinase (IKK), and protein kinase C (PKC) (164).  
 
3. 4. 4 Sulfenylation 
 Sulfenylation (SOH) is an oxidation in cysteine residue of proteins induced by 
reactive oxygen species (ROS), such as hydrogen peroxide (H2O2) and superoxide (.O2-). 
Sulfenylation is considered to be the intermediate for redox-signaling as the process of 
deleterious oxidative damage (143). Sulfenic acid is reactive and unstable with short life span 
in the cells. Sulfenylation of proteins were identified in a relatively small number of proteins 
because the identification of this modification remains difficult (142). Forty seven 
sulfenylated-proteins have been identified by crystal structure analysis (167). The regulation 
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and mechanism of sulfenylation in proteins are not well studied because crystal structure 
analysis and direct mass analysis are problematic for the identification of sulfenylation (143).   
 
4. The regulation of S-nitrosylation and S-sulfhydration 
 So far, there is no report about the regulatory mechanisms of protein S-sulfhydration, 
whereas many studies have been conducted to analyze the regulation of protein S-
nitrosylation. The knowledge on the regulatory mechanism for S-nitrosylation will definitely 
provide clues for further exploring protein S-sulfhydration.  
 
4. 1 The regulation of S-nitrosylation  
 The regulation of S-nitrosylation by Thioredoxin 1 (Trx1) has been reported (168-
171). It was suggested that Trx1 acts a denitrosylase and/or transnitrosylase. Trx1 mediates 
denitrosylation of caspase3 and TrxR is also involved in the denitrosylation of caspase3 (170). 
Denitrosylation of Trx1 is dependent on the cysteine 32 and 35 in Trx1 (132). However, the 
transnitrosylation activity of Trx1 relies on cysteine 69 and 73 in Trx1. S-nitrosylation of 
nuclear factor κB (NF- κB) inhibits its activity and Trx1 increases cytokine-induced NF-κB 
activation through the denitrosylation of NF- κB (169). Cysteine 69 in Trx1 plays a critical 
role for the transnitrosylation of proteins in redox regulation and anti-apoptotic functions of 
Trx1 (168). Trx1 is S-nitrosylated itself and S-nitrosylation of Trx1 transnitrosylates proteins 
which are related to apoptosis, such as caspase-3 and apoptosis signal-regulating kinase 1 
(ASK1) (172,173). Cyteine 73 of Trx1 also plays an important role for the transnitrosylation 
of target proteins which are interacted with Trx1 (132). The target proteins of denitrosylation 
or transnitrosylation by Trx1 are shown in Table 1. 3 and 1.4.  S-nitrosylation of diverse 
proteins is regulated by Trx1 and Trx1 acts differently in target proteins. Detail regulatory 
mechanism of protein S-nitrosylation by Trx1 still is not clear.
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Table 1. 3 Target proteins and peptides denitrosylated by Trx1 (174).  
Protein name Swiss-Prot Identifier Peptide 
40S ribosomal protein S4, X 
isoform  RS4X K.FDTGNLCMVTGGANLGR.I 
40S ribosomal protein SA  RSSA R.ADHQPLTEASYVNLPTIALCNTDSPLR.Y 
40S ribosomal protein SA  RSSA R.YVDIAIPCNNK.G 
60S acidic ribosomal protein P1  RLA1 K.ALANVNIGSLICNVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.K 
ATP-dependent RNA helicase A  DHX9 K.SSVNCPFSSQDMK.Y 
Cofilin-1  COF1 K.AVLFCLSEDKK.N 
Cytoplasmic dynein 1 heavy 
chain 1  DYHC1 K.TSAPITCELLNK.Q 
Dihydropyrimidinase-related 
protein 2  DPYL2 R.GLYDGPVCEVSVTPK.T 
Dopamine beta-hydroxylase  DOPO K.VISTLEEPTPQCPTSQGR.S 
Elongation factor 1-alpha 1  EF1A1 K.SGDAAIVDMVPGKPMCVESFSDYPPLGR.F 
Elongation factor 2  EF2 R.ETVSEESNVLCLSK.S 
Eukaryotic translation initiation 
factor 5A-1  IF5A1 K.KYEDICPSTHNMDVPNIK.R 
Far upstream element-binding 
protein 1  FUBP1 R.SCMLTGTPESVQSAK.R 
Fascin  FSCN1 R.LSCFAQTVSPAEK.W 
Filamin-A  FLNA K.IVGPSGAAVPCK.V 
Galectin-1  LEG1 K.DSNNLCLHFNPR.F 
Glyceraldehyde-3-phosphate 
dehydrogenase  G3P R.VPTANVSVVDLTCR.L 
Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) subunit 
beta-1 
 GBB1 R.LFVSGACDASAK.L 
Heterogeneous nuclear 
ribonucleoprotein H  HNRH1 R.DLNYCFSGMSDHR.Y 
Heterogeneous nuclear 
ribonucleoprotein H  HNRH1 R.YGDGGSTFQSTTGHCVHMR.G 
Heterogeneous nuclear 
ribonucleoprotein K  HNRPK K.GSDFDCELR.L 
Heterogeneous nuclear 
ribonucleoprotein L  HNRPL R.VFNVFCLYGNVEK.V 
Heterogeneous nuclear 
ribonucleoproteins A2/B1  ROA2 K.LTDCVVMR.D 
High mobility group protein B1  HMGB1 K.MSSYAFFVQTCR.E 
High mobility group protein B1  HMGB1 K.RPPSAFFLFCSEYRPK.I 
L-lactate dehydrogenase A chain  LDHA R.VIGSGCNLDSAR.F 
Malate dehydrogenase, 
cytoplasmic  MDHC K.VIVVGNPANTNCLTASK.S 
Myosin light chain 6B  MYL6B K.ILYSQCGDVMR.A 
Nucleoside diphosphate kinase B  NDKB R.GDFCIQVGR.N 
Phosphoglycerate kinase 1  PGK1 K.ACANPAAGSVILLENLR.F 
Poly(rC)-binding protein 1  PCBP1 R.INISEGNCPER.I 
Prostaglandin E synthase 4  TEBP K.LTFSCLGGSDNFK.H 
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Pyruvate kinase isozymes 
M1/M3  KPYM R.NTGIICTIGPASR.S 
Serine/arginine–rich splicing 
factor 1  SRSF1 R.EAGDVCYADVYR.D 
Small glutamine-rich 
tetratricopeptide repeat-
containing protein alpha 
 SGTA K.AIELNPANAVYFCNR.A 
T-complex protein 1 subunit 
gamma  TCPG R.TLIQNCGASTIR.L 
Triosephosphate isomerise  TPIS R.IIYGGSVTGATCK.E 
Tubulin alpha-1A chain  TBA1A R.TIQFVDWCPTGFK.V 
Tubulin alpha-1B chain  TBA1B R.SIQFVDWCPTGFK.V 
Tubulin beta-2A chain  TBB2A K.LTTPTYGDLNHLVSATMSGVTTCLR.F 
Tubulin beta-2A chain  TBB2A R.EIVHIQAGQCGNQIGAK.F 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1  UCHL1 K.NEAIQAAHDAVAQEGQCR.V 
Voltage-dependent anion-




Table 1. 4 Target proteins and peptides transnitrosylated by Trx1 (174). 
Protein name Swiss-Prot Identifier Peptide  
60S ribosomal protein L12  RL12 R.CTGGEVGATSALAPK.I 
60S ribosomal protein L12  RL12 K.EILGTAQSVGCNVDGR.H 
60S acidic ribosomal protein P0-
like  RLA0L R.AGAIAPCEVTVPAQNTGLGPEK.T 
Alpha-enolase  ENOA K.VNQIGSVTESIQACK.L 
Heat shock cognate 71 kDa protein  HSP7C K.GPAVGIDLGTTYSCVGVFQHGK.V 
Peptidyl-prolyl cis-trans isomerase 
A  PPIA K.KITIADCGQLE.- 
Peptidyl-prolyl cis-trans isomerase 
A  PPIA R.IIPGFMCQGGDFTR.H 




4. 2 The regulation of S-sulfhydration  
 Protein S-sulfhydration shares many similar properties with S-nitrosylation. Firstly, 
both of them occur in the cysteine residues on the proteins. Secondly, formation of S-
sulfhydration may depend on a chemical reaction similar to other cysteine modifications, 
such as S-nitrosylation, S-glutathionylation, and sulfenylation, but not phosphorylation. 
Thirdly, they all belong to redox modifications on cysteine residues. The detail mechanisms 
on the regulation of protein S-sulfhydration has not been determined yet. In forming 
mechanism of S-nitrosylation, S-nitrosogluathione (GSNO) is a candidate as a S-nitrosylating 
agent. NO itself can induce S-nitrosylation but it was shown that GSNO may be an 
intermediate for the forming of S-nitrosylation in proteins (175,176). Especially, GSNO/GSH 
ratio is responsible for the S-nitrosylation of GAPDH in Arabidopsis thaliana (175). 
Glutathione persulfide (GSSH) is suggested as a S-sulfhydrating agent (162). Similar to the 
formation of S-nitrosylation, GSSH/GSH ratio may influence on the formation of S-
sulfhydration on proteins. Compared to regulation of protein S-nitrosylation by other proteins, 
such as Trx1, the understanding of the regulation of protein S-sulfhydration is still in its early 
stages. However, the regulation of protein S-sulfhydration by other proteins may be similar to 
the regulation of protein S-nitrosylation as described above if the similarity of protein S-
nitrosylation and S-sulfhydration is considered. Therefore, Trx1 may be a candidate for the 
regulation of protein S-sulfhydration as a trans/de-sulfhydrase. Further study on the 




HYPOTHESIS & OBJECTIVES OF THE STUDY 
 
 S-sulfhydration is considered as a novel post-translational modification of protein, 
which mediates most of the activities of H2S in biological system. H2S is required for 
maintenance of normal liver function. Here, we hypothesized that H2S induces 
gluconeogenesis in liver through PC S-sulfhydration, and Trx1 is involved in the regulation of 
protein S-sulfhydration. The objectives of this study are to: 
 
1. Determine the effects of exogenous and endogenous H2S on gluconeogenesis in liver 
through S-sulfhydration of PC. 
2. Evaluate the difference of PC S-sulfhydration in pathological conditions, such as obesity. 
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2. 1 Abstract 
Cystathionine gamma-lyase (CSE)-derived hydrogen sulfide (H2S) possesses diverse 
roles in the liver, affecting lipoprotein synthesis, insulin sensitivity, mitochondrial 
bioenergetics and biogenesis. H2S S-sulfhydration is now proposed as a major mechanism for 
H2S-mediated signaling. Pyruvate carboxylase (PC) is an important enzyme for 
gluconeogenesis. S-sulfhydration regulation of PC by H2S and its implication in 
gluconeogenesis in liver have been unknown. In the present study, we demonstrated that 
exogenously applied H2S stimulates PC activity and gluconeogenesis in both HepG2 cells (a 
human hepatocellular liver carcinoma cell line) and mouse primary liver cells. CSE 
overexpression enhanced but CSE knockout reduced PC activity and gluconeogenesis in liver 
cells, and blockage of PC activity abolished H2S-induced gluconeogenesis. We further found 
that H2S has little effect on the expressions of PC mRNA and protein, while H2S S-
sulfhydrates PC in a dithiothretiol-sensitive way. PC S-sulfhydration was significantly 
strengthened by CSE overexpression but attenuated by CSE knockout, suggesting that H2S 
enhances glucose production through S-sulfhydrating PC. Mutation of cysteine 265 in human 
PC diminished H2S-induced PC S-sulfhydration and activity. In addition, high fat diet feeding 
of mice decreased both CSE expression and PC S-sulfhydration in liver, while glucose 
deprivation of HepG2 cells stimulated CSE expression. The finding displays a novel 
physiological signaling for H2S regulation of gluconeogenesis via S-sulfhydrating PC in liver.  
 






2. 2 Introduction 
Hydrogen sulfide (H2S) is considered as a novel gasotransmitter that plays a critical 
role in liver functions, including lipoprotein synthesis, insulin sensitivity, mitochondrial 
bioenergetics and biogenesis, and detoxification of various metabolites etc. 
(95,96,99,104,177). In analogy with protein S-nitrosylation, protein S-sulfhydration has been 
proposed as a major mechanism for H2S-mediated signaling (94,178,179). H2S can be 
endogenously produced in a variety of cells, tissues, organs, and systems by cystathionine 
beta-synthase, cystathionine gamma-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase. 
The expressions of these genes are tissue-specific (2,5). Compared with all other tissues in 
the body, all these three genes are expressed in liver with a large amount of H2S production 
(37,94,95,180). Deficiency of CSE gene diminished H2S production by more than 90% in 
mouse liver, suggesting CSE acts as a major H2S-generating enzyme in liver (37,94). Altered 
hepatic H2S generation and metabolism have been demonstrated to be involved in the 
pathogenesis of many liver diseases, such as ischemia/reperfusion injury, hepatic fibrosis and 
cirrhosis (100-103).  
Pyruvate carboxylase (PC; EC6.4.1.1) is a nuclear encoded mitochondrial enzyme 
that catalyses pyruvate to form oxaloacetate (105). PC serves two biosynthetic purposes: it 
sustains the level of oxaloacetate in the tricarboxylic acid cycle, and it provides oxaloacetate 
for phosphoenolpyruvate carboxykinase to convert to phosphoenolpyruvate (129). 
Phosphoenolpyruvate can be converted into glucose, therefore, PC is considered as an 
enzyme that is crucial for intermediary metabolism, controlling fuel partitioning toward 
gluconeogenesis (129). Gluconeogenesis is a ubiquitous process, present in animals, plant, 
fungi, and other microorganisms. In animals, gluconeogenesis takes place mainly in the liver 
(181). In the fed state, the liver stores energy as glycogen from glucose. Conversely, when 
plasma glucose concentration is decreased during fasting or under nutrition, the liver 
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produces glucose through glycogenolytic and gluconeogenic pathways (182). PC is positively 
regulated by glucagon and glucocorticoids while negatively regulated by insulin (183). H2S 
regulation of PC expression and/or activity as well as its involvement in liver 
gluconeogenesis is not clearly understood. 
In the present study, we performed detailed investigation on H2S modification of PC 
protein by S-sulfhydration and the actual S-sulfhydration site(s), and explored the functional 
relevance of PC S-sulfhydration in liver glucose production. By using human hepatocellular 
liver carcinoma cell line (HepG2) and mouse primary hepatocyte isolated from both wild-
type (WT) mice and CSE knockout (CSE-KO) mice, we found that H2S induces PC activity 
directly by S-sulfhydrating PC protein at cysteine 265, and increased PC activity contributes 
to H2S-stimulated gluconeogenesis. We further demonstrated that high fat diet (HFD) feeding 
decreases both CSE expression and PC S-sulfhydration in mouse liver. This study advances 




2. 3 Materials and methods 
Cell culture and animal preparation 
 HepG2 and HEK293 cells (American Type Culture Collection, Manassas, VA) were 
maintained in Dulbecco’s Modified Eagle’s medium (DMEM, Sigma, Oakville, ON) 
supplemented with 10 % fetal bovine serum (FBS, Clontech, Mountain View, CA) and 1 % 
penicillin-streptomycin solution (Sigma). For overexpression of PC and CSE, recombinant 
hPC, or PC mutant plasmids, or CSE cDNA plasmid (184) was transfected into HEK293 or 
HepG2 cells using LipofectamineTM 2000 reagent as described by the manufacturer’s 
protocol (Invitrogen, Burlington, ON). Before treatment with high glucose, HepG2 cells and 
primary liver cells were pre-incubated overnight in DMEM containing 1 % FBS and 1 mM 
glucose and then subjected to 25 mM glucose for additional 24 hours.      
CSE-KO mice were generated as previously described (37). All animal experiments 
were conducted in compliance with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996) 
and approved by the Animal Care Committee of Lakehead University, Canada. Animals were 
maintained on standard rodent chow and had free access to food and water. For high-fat diet 
(HFD, paigen-type) feeding, mice were initially fed with a standard rodent chow diet (Rodent 
RQ 22–5, Zelgler Bros Inc, PA) until 6 weeks of age and then switched to either a HFD 
(TD.02028, Harlan Tekald, Madison, WI) or control diet (TD.05230, Harlan Tekald, Madison, 
WI) for 12 weeks. In all HFD feeding experiments, we followed the procedure according to 
previous study (96). 
 
Isolation of primary liver cells 
 Hepatocytes were isolated from 12-week-old male WT and CSE-KO mice as 
described previously with modification (185). Briefly, liver organ were perfused through the 
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inferior vena cava with a buffer (140 mM NaCl, 2.6 mM KCl, 0.28 mM Na2HPO4, 5 mM 
glucose, and 10 mM HEPES (pH 7.4)). The perfusion was first for 5 min with buffer A (0.5 
mM EGTA) and then for 10 min with buffer B (5 mM CaCl2 and 100 U/ml collagenase type 
IV) (Worthington, Lakewood, NJ). All solutions were pre-warmed at 37 oC incubator. The 
isolated hepatocytes were filtered on nylon mesh (100 μm pore size), and selected by 
centrifugation in a 36 % Percolliso density gradient. Selected cells were seeded in collagen-
coated plates with DMEM containing 10 % fetal bovine serum and 5.5 mM glucose. 
 
PC activity 
 For the measurement of PC activity, coupled enzyme assay was employed as 
described previously (186). Briefly, cells or liver tissues were sonicated in a buffer containing 
10 mM HEPES (pH 7.4), 250 mM sucrose, 2.5 mM EDTA, 2 mM cysteine, 0.02 % bovine 
serum ablumin, and then centrifuged at 13,000 g for 30 min at 4 oC. Collected extract was 
then added to reaction buffer containing 80 mM Tris/HCl (pH 8.0), 2 mM ATP, 8 mM 
potassium pyruvate, 21 mM KHCO3, 9 mM MgSO4, 0.16 mM acetyl CoA, 0.16 mM reduced 
nicotinamide adenine dinucleotide (NADH), and 5 U/ml malate dehydrogenase. The activity 
of PC was calculated by the conversion of NADH to NAD+ with the measurement of the 
change in absorbance at 340 nm over time. Absorbance at 340 nm was measured in a 
multicell spectrophotometer (Fisher Scientific, Ottawa, ON) and the PC activity was 
expressed as nmol/min/mg of total protein. Data was normalized by protein concentration 
determined by the Bradford method. 
 
Biotin switch assay of S-sulfhydration 
 BSA was carried-out as described previously with some modifications (94). Briefly, 
cells or mouse liver tissues were homogenized in HEN buffer (250 mM HEPES (pH 7.7), 1 
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mM EDTA, and 0.1 mM Neocuproine) supplemented with 100 μM deferoxamine and 
centrifuged at 13,000 x g for 30 min at 4°C. The lysates were added to blocking buffer (HEN 
buffer adjust to 2.5% SDS and 20 mM methyl methanethiosulfonate (MMTS)) at 50°C for 20 
min with frequent vortexing. The MMTS was then removed by acetone and the proteins were 
precipitated at -20°C for 20 min. Proteins were resuspended in HENS buffer (HEN buffer 
containing 1 % SDS) and 4 mM biotin-N-[6-(biotinamido) hexyl]-3’-(2’-pyridyldithio) 
propinamide (HPDP) in DMSO without ascorbic acid. After incubation for 2 h at 25°C, 
biotinylated proteins were purified by streptavidin-agarose beads, which were then washed 
with HENS buffer. The biotinylated proteins were eluted by SDS-PAGE sample buffer and 
subjected to Western blotting analysis with anti-PC antibody or anti-His6 antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA).  
 
Western blotting 
 The cells or mouse liver tissues were harvested and lysed in a cell lysis buffer (Cell 
signaling, Danvers, MA) including protease inhibitor cocktail (Sigma). The extracts were 
separated by centrifugation at 14,000 g for 15 min at 4°C. Equal amount of proteins were 
boiled in 1 × SDS sample buffer (62.5 mM Tris-Cl (pH 6.8), 2% SDS, 10% glycerol, 50 mM 
DTT, and 0.01% bromophenol blue) and run in a 10% SDS-PAGE gel, and then transferred 
onto pure nitrocellulose blotting membranes (Pall Corporation, Ville St. Laurent, QC). The 
dilutions of primary antibodies were 1:500 for PC (Santa Cruz Biotechnology), 1:500 for 
His6 (Santa Cruz biotechnology), 1:1,000 for CSE (Proteintech, Chicago, USA), 1:10,000 for 
β-actin (Sigma), and HRP-conjugated second antibody was diluted as 1:5,000 (Sigma). The 





Glucose production in HepG2 and primary hepatocytes 
 HepG2 cells or primary hepatocytes were planted in 6-well plates at a density of 1.5 
× 105/ well at 37 oC in a humidified atmosphere (5% CO2) for 24 h. Cells were then washed 
twice with cold PBS (phosphate buffered saline) to remove excess glucose from the media 
and then incubated for another 3 h in glucose and phenol red-free DMEM containing 2 mM 
sodium pyruvate and 20 mM sodium lactate (pH 7.4). Medium (300 μl) were collected for 
glucose measurement using glucose assay kit (Sigma). Glucose concentration was normalized 
with cellular protein content.  
 
Site-directed mutagenesis 
 Human PC cDNA construct was purchased from Origene (Rockville, MD). PC 
cDNA was cloned into pcDNA3.1/Myc-His tag (Invitrogen). Single mutation at cyteine-265 
(hPC-C265) or cysteine-739 (hPC-C739) in PC was conducted using the Quick Change Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA) (34). The oligonucleotides using for 
mutagenesis were 5’- TGTACGAGCGAGACTCCTCCATCCA-GCGGCG-3’ (forward) and 
5’-GCCGCTGGATGGAGGAGTCTCGCTCGTACAG-3’ (reverse) for cysteine-265, and 5’-
CGAGCTGGCACCCACATCCTGTCCATCAAGGACAT-3’ (forward) and 5’-
ATGTCCTTGA-TGGACAGGATGTGGGTGCCAGCTCG-3’ for cysteine-739. The site-
directed mutants were confirmed by DNA sequencing at the Paleo-DNA Laboratory of 
Lakehead University, ON, Canada. 
 
Immunohistology 
 Mouse livers were dissected out and fixed in 4% paraformaldehyde for 18 h and then 
cryoprotected in 30% sucrose/phosphate-buffered saline at 4 °C for 3 days. Samples were 
embedded in optimal cutting temperature compound (Triangle Biomedical Sciences, Durham, 
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NC).  Sections were then cut into 10-μm with Leica CM1850 UV microtome-cryostat (Leica 
Biosystems, Concord, ON) and picked up on poly-L-lysine-coated slides. Slides were 
incubated with 2% bovine serum albumin at room temperature for 30 min. Primary antibody 
against PC and CSE was added at 4°C for overnight. Slides were then washed twice with 
PBS following incubation with fluorescent secondary antibody for PC (Goat anti-rabbit IgG, 
Sigma) and for CSE (Rabbit anti-mouse IgG, Sigma) for 1h. The slides were washed twice 
with PBS and mounted with media containing 4',6-diamidino-2-phenylindole. Stained tissue 
sections were observed under a fluorescent microscope (Olympus, Richmond Hill, ON).  
 
Statistical analysis 
 Data were presented as means ± SEM, representing at least three independent 
experiments. Student’s t-test was used to evaluate the difference between two groups. For 
multiple groups, Two ANOVA was employed followed by post-hoc Turkey test using 




2. 4 Results 
H2S increases PC activity 
We first observed that incubation of HepG2 cells with NaHS (a well known H2S 
donor) at as lower as 10 µM significantly increases PC activity by 78.0% (Fig. 2. 1A). The 
stimulatory role of NaHS on PC activity was time-dependent, as NaHS treatment (50 µM) of 
HepG2 cells for 30 min, 2 hrs and 12 hrs induced PC activity by 35.4 %, 69.3 %, and 
105.6 %, respectively (Fig. 2. 1B). We further validated that CSE overexpression in HEK293 
cells enhances PC activity in comparison with the control or vehicle transfected-cells (Fig. 2. 
1C and 1D). CSE is a major source of H2S production in the liver with cysteine as substrate. 
Here we found that PC activity in liver tissues from CSE-KO mice is only 58.5 % of that 
from WT mice (Fig. 2. 1E). NaHS (50 µM) incubation with both WT and CSE-KO liver 
lysates significantly increased PC activity, while cysteine (1 mM) only stimulated PC activity 
in liver lysates from WT mice but not CSE-KO mice (Fig. 2. 1E and 1F). 
 
PC mediates H2S-stimulated glucose production 
To see the functional implication of H2S-stimualted PC activity in liver cells, we 
measured glucose production in HepG2 cells and primary hepatocytes. Incubation of HepG2 
cells with 50 µM NaHS induced glucose production by 29.3 % compared with the control 
cells (Fig. 2. 2A). siRNA-mediated PC knockdown completely reversed NaHS-stimulated 
glucose production (Fig. 2. 2A and 2B), indicating the involvement of PC in H2S-initiated 
glucose production. PC knockdown also significantly decreased the basal level of glucose 
production, while PC overexpession increased glucose production in HepG2 cells (Fig. 2. 2A, 
2C, 2D). We further confirmed that incubation of HepG2 cells with phenylacetic acid (PAA), 
a PC inhibitor, evidently blocks H2S-induced PC activity and glucose production (Fig. 2. 2E 
and 2F). By using primary hepatocytes isolated from both WT and CSE-KO mice, we 
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demonstrated that glucose production is decreased by 55.6 % in CSE-KO hepatocytes in 
comparison with WT hepatocytes (Fig. 2. 2G). Similarly, PAA also significantly blocked 
NaHS-stimulated glucose production in both WT and CSE-KO hepatocytes (Fig. 2. 2G). 
 
H2S S-sulfhyrates PC at cysteine 265  
To investigate how H2S stimulates PC activity, we studied the effects of H2S on PC 
protein and mRNA expression. Interestingly, treatment of HepG2 cells with different 
concentration of NaHS (10-100 µM) for 0.5-12 h did not affect PC protein and mRNA 
expression (Fig. 2. 3A-3C). CSE deficiency also had no effect on PC protein and mRNA 
expressions in mouse liver tissues (Fig. 2. 3D and 3E), suggesting H2S may induce PC 
activity at post-translational level. So next we explored whether H2S induces PC activity 
directly by S-sulfhydrating PC protein with modified BSA. Treatment of HepG2 cells with 
NaHS (10, 50, 100 µM) for 2 h significantly increased PC S-sulfhydration compared to the 
untreated cells, and PC was basically S-sulfhydrated even in the absence of exogenous H2S 
(Fig. 2. 4A). We further demonstrated that NaHS (50 µM) induces PC S-sulfhydration in a 
time-dependement manner. In comparison with the control cells, the level of S-sulfhydrated 
PC was increased by 14.1, 38.0, and 76.9 % after 30 min, 2 h, and 12 h of NaHS incubation, 
respectively (Fig. 2. 4B). PC S-sulfhydration was DTT sensitive, and DTT significantly 
reduced the basal and H2S-induced PC S-sulfhydration (Fig. 2. 4C). In line with these data, 
DTT also markedly attenuated H2S-induced PC activity in HepG2 cells (Fig. 2. 4D). The 
basal level of PC S-sulfhydration was significantly higher in WT liver than that in CSE-KO 
liver, and the supplement of cysteine further strengthened PC S-sulfhydration in liver lysates 
from WT mice but not CSE-KO mice (Fig. 2. 4E). In addition, CSE overexpression in 
HEK293 cells stimulated PC S-sulfhydration by 40.2 % compared with the control and 
vehicle-transfected cells (Fig. 2. 4F). 
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There are total 13 cysteine residues in human PC protein, and two of them are highly 
conserved among mammalian and microorganism (Fig. 2. 5A) (131,171,187). Through 
bioinformtic analysis, we found only cysteine 265 in human PC (hPC), one of the highly 
conserved cysteine residues, is located in the surface of PC protein, which forms acid-base 
motif and is easily targeted by external stimuli (Fig 2. 5B) (152,158). To validate whether 
cysteine 265 is responsible for PC S-sulfhydration, we mutated cysteine 265 to serine in hPC. 
We also randomly mutated cysteine 739, which is located inside PC protein and could not 
form acid-base. NaHS significantly induced PC S-sulfhydration in hPC-transfected HEK293 
cells, and mutation of Cysteine 265 but not cystiene 739 abolished the basal level of PC S-
sulfhydration. NaHS further strengthened PC S-sulfhydration in cysteine 739 mutant 
transfected cells but failed in Cysteine 265 mutant transfected cells, pointing to the critical 
role of cystiene 265 in PC S-sulfhydration (Fig. 2. 5C). Consistently, NaHS induced more PC 
activity in both hPC and cysteine 739 mutant transfected cells when compared with Cysteine 
265 mutant transfected cells (Fig. 2. 5D).     
 
Reduced liver CSE expressioin and PC S-sulfhydration in high fat diet (HFD)-feeding 
mice 
We first found that HFD feeding of WT mice for 12 weeks decreases liver PC S-
sulfhydration by 37.5 % compared with the control diet-feeding WT mice (Fig. 2. 6A). Liver 
PC S-sulfhydration was hardly detected in control diet-feeding CSE-KO mice, which was not 
changed by HFD feeding (Fig. 2. 6A). Similar to the change of PC S-sulfhydration, liver PC 
activity was decreased by 22.1 % in HFD-feeding WT mice comparing to control diet-
feeding WT mice (Fig. 2. 6B), and PC activity was not altered in CSE-KO liver under either 
control diet or HFD feeding (Fig. 2. 6B). With immunohistology, we observed that HFD 
feeding significantly decreases CSE expression in WT mice (Fig. 2. 6C). As expected, CSE 
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expression was undetectable in CSE-KO mice with control diet or HFD feeding (Fig. 2. 6C). 
We next determined that high glucose (25 mM) treatment of both HepG2 cells and primay 
hepatocytes reduced CSE expression by 76.9 % and 86.0 %, respectively (Fig. 2. 6D and 6E). 
In parallel of lower CSE expression, PC S-sulfhydration was also significantly reduced by 
high glucose incubation (Fig. 2. 6D). Differently, compared with the control cells, CSE 
expression was increased by 42.2 % and 49.0 % in glucose deprived-HepG2 and primary 




2. 5 Discussion 
 PC is an important enzyme in gluconeogenesis along with fructose-1,6-
bisphosphatase, glucose-6-phosphatase, and phosphoenolpyruvate carboxylase (106,188,189). 
PC expression and activity in human is greatest in hepatic cells, where PC catalyzes the first 
committed step in gluconeogenesis and is well poised to regulate hepatic glucose balance 
(190). PC provides the oxaloacetate for both gluconeogenesis and the replenishment of TCA 
cycle intermediates (90). Altered liver PC activity has been directly correlated with the 
pathophysiology of Type 2 diabetes, obesity and other metabolic syndrome (116,126,183). 
Given the importance of PC in gluconeogenesis, it is essential to fully understand the 
fundamental catalytic and regulatory mechanism of PC activity.  
In the present study, we demonstrated that H2S, a novel gasotransmitter, stimulates PC 
activity in liver cells, while deficiency of CSE in mouse liver tissues attenuates PC activity. 
We previously reported that H2S plays a critical role in regulating gluconeogensis in liver 
(98). Gluconeogenesis is a metabolic pathway that results in the generation of glucose from 
non-carbohydrate carbon substrates, which mainly occurs in liver tissue. To investigate 
whether increased PC activity is involved in H2S-induced gluconeogenesis, we used a loss-
of-function approach. Consistent with our previous discoveries, exogenously applied H2S or 
CSE overexpression significantly induced gluconeogenesis in liver cells. siRNA-mediated 
knockdown of PC mRNA or inhibition of PC activity by PAA blocked H2S-strenthenghed 
gluconeogenesis, clearly indicating the mediation of PC in H2S-induced glucose generation. 
Gluconeogenesis has been the target of therapy for diabetes, and inhibition of CSE/H2S 
pathway would decrease PC activity and lower glucose formation (90,98). Besides with PC, 
many other enzymes are involved in the process of gluconeogenesis (90). It has been reported 
that H2S enhances renal and liver gluconeogenesis by activating peroxisome proliferation-
activated receptor-γ-1α, fructose-1,6-bisphoaphatase and PEPCK (98,191). Nevertheless, it is 
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not clear how H2S regulates the activities of these gluconeogenesis-related enzymes.   
Our next focus is to study how H2S affects PC activity. H2S-induced activation of PC 
is not caused by increased PC transcription and translation, because both PC mRNA and 
protein expressions are not changed by exogenously applied NaHS, CSE overexpression or 
CSE knockout in liver cells. H2S has been recently demonstrated to post-translational 
modification of proteins by formation of a persulfide (-SSH) bond to reactive cysteine 
residues of target proteins, termed as S-sulfhydration (94). Interestedly, we observed that PC 
is basically S-sulfhydrated and PC S-sulfhydration further enhanced by H2S. Lack of CSE 
significantly reduced but overexpression of CSE stimulated PC S-sulfhydration. To locate the 
responsible cysteine residue for H2S S-sulfhydration of PC, we considered three aspects: the 
conservativeness of cysteine residue among species, the accessibility by H2S, and the 
potential acid-base motif (152,158,192,193). The conserved amino acid residue(s) among 
various species can be often targeted by external stimuli (192,194,195). Accessibility of H2S 
to the target cysteine residue is critical for forming S-sulfhydration (193). S-sulfhydration is 
also dependent on the acid dissociation constant (pKa) of cysteine residues, and the cysteine 
residue in acid-base motif can be easily targeted by the intermediate which can induce protein 
S-sulfhydration (152,158,179). In consideration of these factors, we found that cysteine-265 
in human PC is highly potential for forming S-sulfhydration. Cysteine-265 in human PC is 
conserved with cysteine-249 in yeast, the latter has been reported to be the target for nitric 
oxide to form S-nitrosylation (128,131). Cysteine-249 in yeast was also involved in the 
binding with K+ and acetyl-CoA (128). With mutation study, we validated that cysteine-265 
in BCdomain of PC protein is responsible for S-sulfhydration, because mutation of cysteine-
265 to serine completely abrogated S-sulfhydration of PC. Cysteine-739 in CTdomain 
appears not responsible for PC S-sulfhydration.  
PC consist of four functional domains, the N-terminal BC domain, the CT domain, the 
５４ 
 
allosteric domain and the C-terminal biotin carboxyl carrier protein domain (129). The 
regulation of PC activity is extensively reliant on the multifarious interactions of various 
factors with the functional domains (107). The crystal structure of PC protein demonstrated 
the active sites for several critical factors, including MgADP, HCO3−, Mg2+ and free biotin, 
are located in BC domain (107). Acetyl CoA is well known as an allosteric activator of PC, 
and the main binding site of acetyl CoA is located in the BC domain, where acetyl CoA 
stabilizes the tetrameric structure of the enzyme, enhances the binding of some substrates, 
and stimulates the reaction rates (107). It is predicted that, by change in electrostatic 
environment, hydrophobicity, contiguity and orientation of aromatic side chains, and 
proximity of target thiols to transition metals or redox centers, S-sulfhydration can alter 
protein conformation and the final function and activity of target proteins (161,162). In line 
with acetyl CoA, we deduced that the interaction of H2S and PC through cysteine-265 in BC 
domain may cause a conformational change in PC protein and alter the binding of MgADP, 
HCO3−, Mg2+ or free biotin with BC domain, which finally trigger higher pyruvate flux and 
gluconeogenesis (107,183). Further kinetic and structural analysis of S-sulfhydrated PC is 
needed to fully define the roles of the interactions of H2S with cysteine-265 and understand 
the mechanism by which it induces enzyme activation. 
Fasting or starvation usually lower endogenous glucose level, in this case, PC activity 
is induced leading to increased pyruvate flux and higher gluconeogenesis (183). In our study, 
we found that glucose deprivation stimulates CSE expression, which would induce H2S 
generation and enhance glucose generation by S-sulfhydrating PC activity. In contrast, HFD 
feeding of mice reduced CSE expression and PC activity, which may inhibit gluconeogenesis 
but induces glycolysis in liver (196,197). Similarly, we also proved that high blood glucose 
decreases CSE expression in the liver cells. In the presence of higher glucose, lower level of 
H2S due to reduced CSE expression would diminish PC S-sulfhydration and eliminate PC 
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activity. Lower PC activity will subsequently attenuate the process of gluconeogenesis and 
decrease glucose production in liver. Following the change of glucose level, CSE expression 
and H2S production can be restored leading to higher PC activity by S-sulfhydration. 
Increased PC activity by S-sulfhydration then activates gluconeogenesis. Therefore, CSE/H2S 
pathway would act as a critical factor for regulating gluconeogenesis and maintaining glucose 
balance in the liver (Fig. 2. 7).  
Taken together, our results indicated that CSE/H2S pathway plays an important role in 
the regulation of glucose production through S-sulfhydrating PC in liver. Tissue-specific 
regulation of CSE/H2S pathway might be a promising therapeutic target of diabetes and other 
components of metabolic syndromes. 
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the control. n=4.  (B) H2S induced PC activity in a time-dependent manner. HepG2 cells 
were incubated with NaHS (50 µM) for 0.5, 2 and 12 h, respectively. For long term treatment 
of NaHS (12 h), HepG2 cells were treated once in every 3 h with replacement of old medium. 
* p<0.05 versus the control. n=4.  (C) and (D) CSE overexpression stimulated PC activity in 
HEK293 cells. HEK293 cells were transfected with CSE cDNA (184) for 24 h to overexpress 
CSE, the cells were then collected to analyze CSE expression and PC activity, respectively. * 
p<0.05 versus all other groups. n=4. (E) H2S induced PC activity in liver tissues. Liver 
lysates from both WT and CSE-KO mice were incubated with 50 µM NaHS for 30 min. * 
p<0.05 versus WT without NaHS treatment; # p<0.05 versus CSE-KO without NaHS 
treatment. (F) Cysteine strengthened PC activity in liver lysates from WT mice but not CSE-
KO mice. Liver lysates from both WT and CSE-KO mice were incubated with 1 mM cysteine 
for 30 min. * p<0.05 versus WT without cysteine treatment. Eight 12-week-old male WT 
















of PC reversed H2S-induced glucose production. HepG2 cells were transfected with PC 
siRNA for 24 h in the presence or absence of NaHS (50 µM), and the cells were then 
collected for analyzing glucose production and PC protein expression. *, p<0.05 versus the 
cells transfected with control siRNA. n=3. (C) and (D) PC overexpession increased glucose 
production in HepG2 cells. HepG2 cells were transfected with PC cDNA for 24 h, the cells 
were then collected for analyzing glucose production and PC protein expression. *, p<0.05. 
n=4. (E) and (F) PAA lowered down H2S-induced PC activity and glucose production. HepG2 
cells were incubated with PAA (1 mM) for 30 min and/or NaHS (50 µM) for 2 h, the cells 
were collected for measuring PC activity and glucose production. *, p<0.05 versus control. 
n=4. (G) glucose production was decreased in CSE-KO hepatocytes. Hepatocytes isolated 
from WT and CSE-KO mice were incubated with PAA (1 mM) for 30 min and/or NaHS (50 
µM) for 2 h, the cells were collected for measuring glucose production. * p<0.05 versus WT 















for the indicated time (0.5-12 h) (B), the cells were then collected and lysed for western 
blotting analysis of PC protein expression (A and B). (C) HepG2 cells were incubated with 
different concentration of NaHS (10-100 µM) for 2 h and real-time PCR analysis of PC 
mRNA expressioin was then performed. n=4 (D) and (E) CSE deficiency did not affect PC 
protein and mRNA expressions in mouse liver tissues. four WT and four CSE-KO mice were 























and PC S-sulfhydration was then analyzed by BSA with anti-PC antibody. * p<0.05 versus 
the control. n=4.  (B) H2S induced PC S-sulfhydration in a time-dependent manner. HepG2 
cells were incubated with NaHS (50 µM) for 0.5, 2 and 12 h, respectively. * p<0.05 versus 
the control. n=4.  (C) and (D) DTT reversed H2S-induced PC S-sulfhydration and PC 
activity. HepG2 cell lysates were incubated with NaHS (100 µM) and/or DTT (1 mM) for 30 
min, the cells were then collected for analyzing PC S-sulfhydration and PC activity, 
respectively. * p<0.05 versus control. n=4. (E) Cysteine strengthened PC S-sulfhydration. 
Both WT and CSE-KO liver lysates were incubated with L-cysteine (1-10 mM) for 30 min. * 
p<0.05 versus WT control. n=4. (F) CSE overexpression stimulated PC S-sulfhydration. 
HEK293 cells were transfected with CSE cDNA (184) for 24 h following detection of PC S-







Figure 2. 6    Reduced liver CSE expression and PC S-sulfhydration in HFD-feeding 
mice. (A) and (B) HFD feeding of WT mice decreased liver PC S-sulfhydration and activity. 
Both WT and CSE-KO mice were feed with HFD for 12 weeks following detection of PCS-
sulfhydration (A) and activity (B). * p<0.05 versus all other groups. n=4. (C) HFD feeding 
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significantly decreased CSE expression in WT mice. Both WT and CSE-KO mice were feed 
with HFD for 12 weeks following detection liver CSE expression by immunohistology. Bar: 
20 µm. (D) and (E) High glucose inhibited CSE expression and PC S-sulfhydration in both 
HepG2 cells and primay hepatocytes. The cells were incubated with different concentration 
of glucose (5.5 and 25 mM) for 24 hours following detection of CSE expression and PC S-
sulfhydration. * p<0.05. n=3. (F) and (G) Glucose deprivation enhanced CSE expression in 
both HepG2 cells and primay hepatocytes. The cells were deprived of glucose for 24 hours 
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3. 1 Abstract 
 The importance of H2S in biology and medicine has been widely recognized in recent 
years, and protein S-sulfhydration is proposed to mediate most of H2S bioactivity in the body. 
Thioredoxin 1 (Trx1) is an important reducing enzyme that cleaves disulfides in proteins and 
acts as an S-denitrosylase. The regulation of Trx1 on protein S-sulfhydration is unclear. Here 
we showed that Trx1 is essential for protein S-desulfhydration. Overexpression of Trx1 
attenuated the basal level and H2S-induced protein S-sulfhydration by direct interacting with 
S-sulfhydated proteins, i.e., glyceraldehyde 3-phosphate dehydrogenase and pyruvate 
carboxylase. Mutation of cysteine-32 but not cysteine-35 in the Trp-Cys32-Gly-Pro-Cys35 
motif eliminated the binding of Trx1 with S-sulfhydated proteins and abolished the S-
desulfhydrating effect of Trx1. In contrast, blockage of Trx1 redox activity with PX12 or 2,4-
dinitrochlorobenzene enhanced protein S-sulfhydration. All these data suggest that Trx1 acts 
as an S-desulfhydrase. 
 
 











3. 2 Introduction 
 Hydrogen sulfide (H2S) can S-sulfhydrate proteins by yielding a hydropersulfide 
moiety (–SSH) in the active cysteine residues (94,198,199). It is predicted that S-
sulfhydration can alter protein conformation and the final function and activity of target 
proteins (160,198). This particular redox modification of cysteine by S-sulfhydration has 
been achieved using proteomics techniques by coupling a specific enrichment strategy 
(biotin-switch assay and/or tag-switch assay) with high-throughput mass spectrometry 
analysis (94,179,200). So far, there have been a dozen proteins observed to be modified by 
H2S through S-sulfhydration. KATP channel is a direct target for H2S in regulating vasodilation 
and cardioprotection (7). In fact, H2S induces S-sulfhydration of Kir6.1 subunit of KATP 
channels, and dithiothreitol (DTT) reverses this S-sulfhydration (160). H2S-induced S-
sulfhydration of phosphatase PTP1B alters endoplasmic reticulum stress response (201). H2S 
S-sulfhydrates p65 and mediates the anti-apoptotic effect of NF-B (179). H2S modulates 
cellular redox signaling via direct S-sulfhydration of Keap1/Nrf2 system, p66, and 
electrophiles, contributing to the beneficial effects of H2S on cellular aging and heart failure 
(34,202,203). S-sulfhydration of MEK1 leads to PARP1 activation and DNA damage repair in 
endothelia cells (161). 
Like protein phosphorylation and S-nitrosylation, S-sulfhydration is proposed to 
mediate or modulate transduction of myriad cellular signals (94,198,199). While decades of 
research have established the generality and broad physiological importance of protein 
phosphorylation and S-nitrosylation, our current understanding of the fundamental biology 
and chemistry of S-sulfhydration as a protein signaling modality is still in its infancy 
(170,204). Is H2S S-sulfhydration of cysteine enzyme-regulated or a spontaneous process? 
How is the biochemical stability of S-sulfhydrated proteins? Which critical factors are 
involved and what conditions are required for the formation of S-sulfhydration? Is there any 
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possibility for desulfhydration and/or transsulfhydration and how are they regulated? Little is 
known about the nature of or even necessity for enzymatic mechanisms that may directly add 
or remove SH groups from cysteine thiols.   
In the present study, we demonstrated that thioredoxin 1 (Trx1), an oxidoreductase 
found in both prokaryotes and eukaryotes, is essential for protein S-desulfhydration. 
Overexpression of Trx1 attenuated the basal level and H2S-induced protein S-sulfhydration 
by direct interaction with S-sulfhydated proteins, i.e., glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and pyruvate carboxylase (PC). In contrast, blockage of Trx1 
activity strengthened protein S-sulfhydration. Furthermore, mutation of cyseine-32 in Trx1 
eliminated the binding of Trx1 with S-sulfhydated proteins and abolished the S-




3. 3 Materials and methods 
Cell culture and transfection 
HepG2 (a human hepatocellular liver carcinoma cell line) and HEK293 cells were 
purchased from American Type Culture Collection (Manassas, VA) and maintained in 
Dulbecco’s Modified Eagle’s medium (Sigma, Oakville, ON) supplemented with 10% fetal 
bovine serum (Clontech, Mountain View, CA) and 1% penicillin-streptomycin solution 
(Sigma). For cell transfection, wild-type Trx1 or mutant Trx1 was transfected into HEK293 
or HepG2 cells using LipofectamineTM 2000 reagent as described by the manufacturer’s 
protocol (Invitrogen, Burlington, ON).  
 
Biotin switch assay of S-sulfhydration 
 BSA was carried-out as described previously with some modifications (94). Briefly, 
the cells were homogenized in HEN buffer (250 mM HEPES (pH 7.7), 1 mM EDTA, and 0.1 
mM Neocuproine) supplemented with 100 μM deferoxamine and centrifuged at 13,000 × g 
for 30 minutes at 4°C. The lysates were added to blocking buffer (HEN buffer adjust to 2.5% 
SDS and 20 mM methyl methanethiosulfonate (MMTS)) at 50°C for 20 minutes with 
frequent vortexing. The MMTS was then removed by acetone and the proteins were 
precipitated at -20°C for 20 min. Proteins were resuspended in HENS buffer (HEN buffer 
containing 1 % SDS) and 4 mM biotin-N-[6-(biotinamido) hexyl]-3’-(2’-pyridyldithio) 
propinamide (HPDP) in DMSO without ascorbic acid. After incubation for 2 hours at 25°C, 
biotinylated proteins were purified by streptavidin-agarose beads, which were then washed 
with HENS buffer. The biotinylated proteins were eluted by SDS-PAGE sample buffer and 
subjected to Western blotting analysis with antibody against GAPDH or PC.  
 
Construction of Trx1 mutants 
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 The plasmid Myc-TRX was purchased from Addgene (MA, USA) (205). Single 
mutation of cyteine-32 (Trx1-C32) and cysteine-35 (Trx1-C35) to serine were conducted 
using the Quick Change Site-Directed Mutagenesis kit (Stratagene, CA, USA) (161). The 
oligonucleotides using for mutagenesis were 5’- 
CTTCTCAGCCACGTGGAGTGGGCCTTGCAAAATG-3’ (forward) and 5’-
CATTTTGCAAGG-CCCACTCCACGTGGCTGAGAAG-3’ (reverse) for cysteine-32, and 
5’-CGTGGTGTGGGCC-TAGCAAAATGATCAAGC-3’ (forward) and 5’-
GCTTGATCATTTTGCTAGGCCCACACCACG-3’ for cysteine-35. The correct mutant was 
confirmed by DNA sequencing at the Paleo-DNA laboratory in Lakehead University, ON, 
Canada. 
 
Co-Immunoprecipitation (Co-IP)  
 The cells were lysed in IP lysis/wash buffer (25 mM Tris, 0.15M NaCl, 1 mM EDTA, 
1% NP-40, 5% glycerol, pH7.4) including protease inhibitor cocktail (Sigma) (34). The 
proteins (500 µg) were then incubated with 5 μg anti-PC antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA) or anti-GAPDH (Santa Cruz Biotechnology) for overnight at 4 oC. Protein 
A/G agarose was incubated with lysates for 1 hour with gentle end-over-end mixing. Agarose 
resin was washed three times with IP lysis/wash buffer. The resin was then washed one time 
with saline solution (0.15 M NaCl). Immune complex was eluted with 2 × SDS PAGE sample 
buffer (62.5 mM Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT, and 0.01% 




 The cells were harvested and lysed in a cell lysis buffer including protease inhibitor 
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cocktail (Sigma). Extracts were separated by centrifugation at 14,000 g for 15 min at 4°C. 
SDS-PAGE and Western blot analysis were performed. Briefly, equal amount of proteins 
were boiled in 1 × SDS sample buffer and run in a 10% SDS-PAGE gel, and transferred onto 
pure nitrocellulose blotting membranes (Pall Corporation). Immunoblots were probed with 
mouse monoclonal anti-PC (1:500 dilution; Santa Cruz Biotechnology), anti-GAPDH 
(1:1,000 dilution; Santa Cruz Biotechnology) and horseradish peroxidase (HRP)-conjugated 
rabbit anti-mouse secondary antibody (1:10,000 dilution; Sigma). Anti-β-actin primary 
antibody (1:10,000 dilution; Sigma) and HRP-conjugated rabbit anti-mouse secondary 
antibody (1:5,000 dilution; Sigma) were employed to normalize protein expression. The blots 
were developed using chemiluminescence (ECL Western Blotting Detection Reagents, 
Amersham Biosciences).  
 
Statistical analysis 
 Data were presented as means ± SEM, representing at least three independent 
experiments. Statistical comparisons were made using Excel 2007 (Microsoft, Redmond, 
WA) with Student’s t-test to evaluate the difference between two groups, and the difference 
between multiple groups were analyzed by using SigmaPlot 12.0 (Systat Software Inc. San 





Trx1 suppresses protein S-sulfhydration 
Protein S-sulfhydration can be detected by the modified BSA (94). Following the 
procedures descried in the Methods, the S-sulfhydrated thiols were labeled with biotin-HPDP 
and then detected by western blotting with the antibody against either biotin or specific 
protein. We first detected the basal labeling of multiple proteins using an antibody against 
biotin, and the signaling became even stronger after treatment with 50 µM NaHS (a well 
known H2S donor) for 2 hours in HEK293 cells. We further found that Trx1 overexpression 
in HEK293 cells markedly decreases H2S-induced protein S-sulfhydration (Fig. 3. 1A). 
Probing with antibodies to specific proteins, such as PC (Fig. 3. 1B) and GAPDH (Fig. 3. 1C), 
it was clearly showed that both GAPDH and PC proteins were basically S-sulfhydrated and 
further strengthened by exogenously applied NaHS, while transfection of HEK293 cells with 
Trx1 cDNA significantly reversed the basal and H2S-initiated S-sulfhydration of PC and 
GAPDH, suggesting Trx1 acts as a S-desulfhydrase. Identical results were further validated in 
another cell line, HepG2 cells (Fig. 3. 1D and 1E).  
 
Inhibition of Trx1 activity stimulates protein S-sulfhydration 
PX12, an irreversible and competitive inhibitor of Trx1, significantly enhanced the S-
sulfhydration of PC and GAPDH when compared with the control HepG2 cells (Fig. 3. 2A 
and 2B). Similarly, 2,4-dinitrochlorobenzene (DNCB), an irreversible inhibitor of thioredoxin 
reductase (TrxR), also increased S-sulfhydrated PC and GAPDH (Fig. 3. 2C and 2D), 
suggesting that thioredoxin reductase cooperates with Trx1 contributing to protein S-
desulfhydration. Either PX12 or DNCB did not further increase H2S-stimulated PC and 
GAPDH S-sulfhydration (Fig. 3. 2A-D). Furthermore, we observed that PX12 or DNCB 
significantly reverses the inhibitory role of Trx1 overexpression on S-desulfhydration of PC 
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and GAPDH (Fig. 3. 3A-D).    
 
Cysteine-32 is requisite for Trx1 desulfhydration of proteins 
 Trx1 has a highly conserved active site, Trp-Cys32–Gly–Pro–Cys35, which is required 
for its redox activity (206,207). Here we found that mutation of cysteine-32 but not cysteine-
35 in the Trp-Cys32–Gly–Pro–Cys35 motif eliminates the S-desulfhydration activity of Trx1 on 
both PC and GAPDH (Fig. 3. 4A and 4B), suggesting cysteine-32 is requisite for Trx1 S-
desulfhydration of proteins. Trx1 directly interacted with PC and GAPDH, which was not 
altered in the presence of NaHS. Interestedly, mutation of cysteine-32 but not cysteine-35 




3. 5 Discussion 
 H2S regulates cellular processes largely through S-sulfhydration of active cysteine 
residues within proteins (198,199). S-sulfhydration of proteins has been demonstrated to be 
involved in a broad range of signaling and metabolic pathways, including cell death and 
differentiation, enzymatic activity, protein localization, protein–protein interactions, and 
protein stability, etc (34,94,160,161,178,179,201,203,208). Given the importance of protein 
S-sulfhdyration in both health and diseases, much less is known about the systems governing 
protein S-desulfhydration. In our present report, we demonstrated that Trx1 is essential for 
breakage of hydropersulfide group from the cysteine thiol in S-sulfhdyrated proteins by direct 
interaction with Trx1 at cysteine-32. 
Trx1, a ubiquitous 12 kDa proteins with general anti-oxidative properties, is involved 
in a large number of cellular functions such as cell proliferation and differentiation, redox and 
metabolic pathways, gene transcription, embryogenesis, etc (162,169,173,209,210). In recent 
years, Trx1 has been suggested to mediate cysteine S-denitrosylation by reducing inter- and 
intramolecular disulfide bonds in proteins (153,162). By analogy to S-nitrosylation, the extent 
of S-sulfhydration of a given protein must be governed by the equilibrium between S-
sulfhydration and S-desulfhydration reactions (162). Protein S-sulfhydration is mainly 
dependent on the activity of H2S-producing enzymes (179,211). Here we showed that Trx1 is 
clearly involved in protein S-desulfhydration, because overexpression of Trx1 suppressed but 
blockage of Trx1 activity enhanced protein S-sulfhydration. Trx1 catalyzes thiol-disulfide 
oxidoreductions by using redox-active cysteine residues present in a Trp-Cys32-Gly-Pro-Cys35 
sequence motif (153,169,212). The active cysteine residues form a disulfide in oxidized Trx1, 
while the disulfide is broken in reduced Trx1 with the aid of TrxR using electrons from 
NADPH (169,175). In our study, inhibition of TrxR activity by DNCB must block the 
transition of reduced Trx1 to oxidized Trx1, which diminishes the inhibitory role of Trx1 on 
７８ 
 
protein S-desulfhydration. These findings indicate that protein S-desulfhydration is indeed 
mediated by the Trx1/TrxR system. 
We further provided evidence that Trx1 contributes to protein S-desulfhydration via 
protein-to-protein association between its substrate and Trx1 at cysteine-32. Co-
immunoprecipitation results demonstrated that Trx1 directly interacts with S-sulfhydrated 
proteins, and single mutation of cysteine-32 to serine abolished the inhibitory role of Trx1 on 
protein S-desulfhydration. Mutation of cysteine-32 also eliminated the binding of Trx1 with 
S-sulfhydrated proteins. In contrary, mutation of cysteine-35 in the same Trp-Cys32-Gly-Pro-
Cys35 sequence motif failed to change the S-desulfhydration activity of Trx1. There may be 
several reasons for this difference. Firstly, formation of the cysteine-32/cystine-35 disulfide 
bridge leads to a rotation of the side-chain of cysteine-32 away from cysteine-35 in the 
reduced form (207,210). Mutation of cysteine-32 will induce formation of new disulfide 
between cysteine-35 and other cysteine residues within Trx1, which would change the 
position of cysteine 32 and block the interaction of cysteine-32 with S-sulfhydrated proteins. 
Secondly, the thiol of cysteine-32 has a low pKa value in comparison with cysteine-35, and 
cysteine-32 is more easily attacked by S-sulfhydrated proteins for disulfide reduction 
(169,175,212). Thirdly, Trx-interacing protein (Txnip), a constitutively expressed protein, 
forms a mixed disulfide with the active site cysteine-32 of Trx1 (162,174,206). Mutation of 
cysteine-32 would interrupt the interaction of Txnip with Trx1, thereby affecting the 
oxidoreductase activity of Trx1. More studies are required to elucidate the precise interaction 
of Trx1 cysteine-32 and S-sulfhydrated proteins. In addition, we cannot exclude the 
possibility that other cysteine residues within Trx1 are involved in this process. 
Two major pathways for enzymatic denitrosylation have recently been recognized 
(162). Besides with Trx system, S-nitrosoglutathione (GSNO) reductase also can lower the 
levels of protein S-nitrosothiols (162,207,213). Unlike Trx1, which directly target specific S-
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nitrosylated proteins for cysteine reduction, GSNO reductase indirectly decreases cell protein 
S-nitrosylation through GSNO metabolism. In addition, glutathione, the most abundant 
intracellular thiols, plays a major role in protein S-denitrosylation by GSNO reductase. We 
had data showed that the supplemental of glutathione has no effect on protein S-
desulfhydration. Therefore, GSNO reductase would not act as an S-desulfhydrase. 
Based on these results above, we conclude that the S-desulfhydration of proteins is 
associated with the Trx1/TrxR system, and cysteine-32 within Trx1 is responsible for the 
direct interaction of Trx1 and S-sulfhydrated proteins following the breakage of 
hydropersulfide group. Further investigation on the role of Trx system in relation to protein S-
desulfhydation and their biological relevance needs to be explored. 
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Figure 3. 1    Trx1 acts as an S-desulfhydrase. (A), (B), and (C) Trx1 overexpression 
inhibited the S-sulfhydration level of total proteins, PC and GAPDH in HEK293 cells. 
HEK293 cells were transfected with Trx1 cDNA for 24 hours, and then treated with 50 µM 
NaHS for 2 hours. After that, the cells were collected for BSA using antibody against biotin 
(A), PC (B), and GAPDH (C), respectively. * p<0.05 versus all other groups; # p<0.05 versus 
control. n=4. (D) and (E) Trx1 overexpression inhibited PC and GAPDH S-sulfhydration in 
HepG2 cells. HepG2 cells were transfected with Trx1 cDNA for 24 hours, and then treated 
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with 50 µM NaHS for 2 hours. After that, the cells were collected for BSA using antibody 
against PC (D) and GAPDH (E), respectively. * p<0.05 versus all other groups; # p<0.05 






Figure 3. 2    Inhibition of Trx system enhances protein S-sulfhydration.  (A) and (B) 
PX12 induces PC and GAPDH S-sulfhydration. HepG2 cells were firstly treated with 5 µM 
PX12 for 4 hours, and then 50 µM NaHS was added for additional 2 hours. After that, the 
cells were collected for BSA using antibody against biotin PC (A) and GAPDH (B), 
respectively. * p<0.05 versus control. n=4. (C) and (D) DNCB induces PC and GAPDH S-
sulfhydration. HepG2 cells were treated with 40 µM DNCB or 30 minutes and/or 50 µM 
NaHS for 2 hours. After that, the cells were collected for BSA using antibody against biotin 






hours following incubation with 5 µM PX12 for 4 hours and/or 50 µM NaHS for 2 hours. 
After that, the cells were collected for BSA using antibody against biotin PC (A) and GAPDH 
(B), respectively. * p<0.05 versus control. n=4. (C) and (D) DNCB reversed the inhibitory 
effect of Trx1 on PC and GAPDH S-desulfhydration. HEK293 cells were firstly transfected 
with Trx1 cDNA for 24 hours following incubation with 40 µM DNCB or 30 minutes and/or 
50 µM NaHS for 2 hours. After that, the cells were collected for BSA using antibody against 







following incubation with 50 µM NaHS for 2 hours. After that, the cells were collected for 






























 H2S is considered as the third gasotransmitter along with NO and CO. Similar to NO 
and CO, H2S plays diverse roles in metabolic and signaling pathways. Recently, it is 
recognized that H2S S-sulfhydration of protein mediates most of H2S activities in various 
cellular functions. Protein S-sulfhydration is analogous to protein S-nitrosylation by NO. 
Protein S-sulfhydration is just newly discovered, many things remain unclear about protein S-
sulfhydration, i.e., the regulatory and forming mechanism of S-sulfhydration, the interaction 
between S-nitrosylation and S-sulfhydration, and their alterations in health and diseases. Here 
we demonstrated that H2S regulates liver gluconeogenesis through S-sulfhydration of PC and 
Trx1 is involved in the regulation of protein S-desulfhydration.  
 In chapter 2, we found that S-sulfhydration of PC induced by H2S increases 
gluconeogenesis in HepG2 and mouse primary liver cells. To date, the post-translational 
modification of PC is poorly understood. The present study showed that PC S-sulfhydration 
occurs in cysteine 265 of human PC, and S-sulfhydration induces PC activity. H2S had no 
effect on the expression of PC. S-sulfhydration of PC is regulated by CSE in liver cells and it 
was further found that high glucose inhibits CSE expression and S-sulfhydration of PC. 
CSE/H2S pathway is involved in the regulation of gluconeogenesis through PC S-
sulfhydration and it is modulated by glucose in liver cells. In the last decade, CSE/H2S 
pathway has been gotten attentions for their pathological and physiological roles in liver. 
However, most studies of H2S in liver are related to its anti-oxidant, bioenergetic, and 
detoxification effects (95). In our previous studies, it was shown that CSE/H2S pathway plays 
critical roles for the metabolisms in liver, such as lipid metabolism (95,96) and glucose 
metabolism (98). Unfortunately, the detail regulation of metabolisms by H2S in liver was not 
fully determined yet. Here, based on my results, we suggest that PC S-sulfhydration regulated 
by CSE/H2S pathway in liver cells is one of the regulatory mechanisms for the glucose 
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metabolism, especially gluconeogenesis. Gluconeogenesis is associated with metabolic 
syndromes, such as diabetes, obesity, and hypertension. For metabolic syndromes, insulin 
resistance is considered as a main pathogenic factor. In our previous studies, it was shown 
that H2S plays a pathological role in the induction of hepatic insulin resistance (98,214). Until 
now, the effect and regulation of CSE/H2S pathway in metabolic syndromes are not well 
determined. In addition, malfunction of CSE/H2S pathway in liver may be related to the 
development of metabolic syndromes because abnormality of CSE/H2S system is often found 
in metabolic syndromes (215). Therefore, protein S-sulfhydration regulated by CSE/H2S 
pathway in liver will be a critical process to regulate metabolic pathways and syndromes 
through CSE/H2S pathway, and protein S-sulfhydration will be an useful therapeutic target for 
metabolic syndromes through the regulation of gluconeogenesis. 
 In chaper 3, we reported that S-sulfhydration of GAPDH and PC are regulated by 
Trx1. Trx1 is a well-known redox related small protein which plays a role as a denitrosylase 
and transnitrosylase. However, the role of Trx1 in regulation of protein S-sulfhydration is not 
clear. Here we found that Trx1 reverses S-sulfhydration of GAPDH and PC and acts as a S-
desulfhydrase. Especially, cysteine 32 but not cysteine 35 in Trx1 is a critical residue for the 
desulfhdyration activity of Trx1. The regulatory mechanism of desulfhydration activity in 
Trx1 by cysteine  32, not cysteine 35, results from the different properties between these two 
cysteines (216). Firstly, in the folding structure of Trx1, cysteine 35 is buried and cysteine 32 
is freely accessible for the interaction with substrate and target residue in biomolecules. Thus, 
cysteine 32 is able to access the S-sulfhydrated cysteine residue. Secondly, cysteine 32 is 
deprotonated at physiological pH and can be allowed for nucleophilic attack on target, such 
as disulfide bond. Persulfide in protein S-sulfhydration shares similar properties with 
disulfide bond. Consequently, cysteine 32 can play a nucleophilic attacker for the persulfide 
in protein S-sulfhydration. Finally, in physiological pH, cysteine 32 acts as an acid and 
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cysteine 35 as a base. Deprotonated and acidic cysteine 32 uptakes HS- from persulfide in 
protein S-sulfhydration and cysteine 35 then plays a role for the release of H2S from Trx1, as 
a base (Fig. 4). The study for the regulatory and forming mechanism of protein S-
sulfhydration is important to understand the effects and roles of H2S in pathological and 
physiological conditions. Unfortunately, up to now there is no report about the regulatory and 
forming mechanism of protein S-sulfhydration. The present study first explored the 
regulatory mechanism of protein S-sulfhydration and demonstrated that Trx1 is essential for 
removal of protein S-sulfhydration . 
 The forming mechanism is an important matter for the study of protein S-
sulfhydration. As mentioned in Chapter 1, the study of forming mechanism of protein S-
sulfhydration is rarely reported. It is unknown whether protein S-sulfhydration is enzyme-
catalyzed reaction or automatic redox reaction but it is clear that many intermediates must be 
in involved the formation of protein S-sulfhydration. RSSH including GSSH and CSSH is a 
highly potential intermediate for the forming of protein S-sulfhydration (162). Furthermore, 
the correlation between H2S and GSSH was determined in different tissues, such as brain, 
kidney, and liver, from mouse. It was suggested that H2S producing enzymes, CSE and CBS, 
are involved in the regulation of GSSH levels and may influence on the forming protein S-
sulfhydration (162). Therefore, further investigation on the forming mechanism of protein S-
sulfhydration will be required to determine regulation of protein S-sulfhydration and 







 The present studies showed that H2S plays an important role in up-regulation of 
gluconeogenesis, through PC S-sulfhydration, and Trx1 acts as a protein S-desulfhydrase.  
 In liver, CSE is mainly responsible for H2S production and contributes to PC S-
sulfhydration. I further found that glucose decreases CSE expression in liver and inhibits PC 
and gluconeogenesis. Malfunction of gluconeogenesis, elevated gluconeogenic activity, is a 
critical factor in metabolic syndromes. Gluconeogenesis is a therapeutic target of these 
syndromes through the inhibitory regulation of gluconeogenesis. Therefore, CSE/H2S 
pathway in liver is a potential therapeutic target for metabolic syndromes and PC S-
sulfhydration is a useful approach to understand the roles and effects of H2S on 
gluconeogenesis.  
 The PC and GAPDH S-sulfhydration are regulated by Trx1. Cysteine 32 among 
active sites in Trx1, but not cysteine 35, plays a critical role for the regulation of protein S-
sulfhydration (Fig. 4). I expect that the present finding about the regulatory mechanism of 
protein S-sulfhydration by Trx1 will provide the basis for the understanding of protein S-





SIGNIFICANCE OF THE STUDY 
 
 Diabetes is a metabolic disease and it is estimated that 387 million people who suffer 
diabetes worldwide as of 2014. Type 2 diabetes makes up about 90 % of the cases which is 
equal to 8.3 % of the adult population. Diabetes can cause many complications, such as 
diabetic ketoacidosis, nonketotic hyperosmolarcoma, cardiovascular disease, stroke, kidney 
failure, foot ulcers, and damage to the eyes. Diabetes resulted in an estimated 1.5 to 4.9 
million deaths per year in the years 2012 to 2014. In Canada, diabetes is involved in over 
41,500 deaths each year. Furthermore, the cost for the diabetes is huge and direct cost ranges 
from $ 1,000 to $ 15,000 per year. In the United States, diabetes cost $ 245 billion in 2012. In 
Canada, Canadian healthcare system estimated that the cost will be $ 16.9 billion per year by 
2020.  
 Until now, the pathogenic mechanisms of diabetes have not been fully understood. 
Clinical therapies according to current mechanisms are not effective as much as expected and 
it is hard to prevent multiple complications caused by diabetes. Increased rates of endogenous 
glucose production by gluconeogenesis were commonly observed in patients with poorly 
controlled type 2 diabetes. Metaformin is a well known therapeutic drug for type 2 diabetes. 
Metaformin exerts its function in type 2 diabetes via inhibition of gluconeogenesis (89). It 
has been shown that H2S is involved in the development and progression of diabetes 
(217,218). The detailed mechanism of H2S in diabetes is still unclear. The regulation of 
CSE/H2S system on glucose balance in liver cells as a cellular response will be beneficial to 
understand the mechanism of diabetes and acts as a potential therapeutic target for diabetes. 
In addition, we demonstrated that H2S is involved in the regulation of gluconeogenesis 
through S-sulfhydration of PC, which provide a direct link for the role of CSE/H2S in 
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diabetes. In diabetic rat model, CSE expression and H2S production are increased (219). 
Pathogenic effects of CSE/H2S pathway in Zucker diabetic rats are found as well (217). 
Therefore, PC S-sulfhydration may act as a pathogenic factor in diabetes. Once detail 
regulation of PC S-sulfhydation and gluconeogenic pathway regulated by H2S is determined, 
it will provide the beneficial way for the therapy of diabetes. 
 S-sulfhydration is a novel posttranslational modification of proteins by H2S. Here we 
firstly reported that protein S-sulfhydration is regulated by Trx1. Further studies on the 
regulatory mechanisms of protein S-sulfhydration will provide the strategies for designing 








 Future directions suggested as a follow-up on this study are: 
 
1. To further investigate the regulatory mechanism of S-sulfhydration. It has been 
well known that S-nitrosylation is extensively regulated via denitrosylation or 
transnitrosylation. I fully believe Trx1 is one of the factors involved for S-
sulfhydration regulation. In order to further investigate the regulatory mechanism 
of protein S-sulfhydration, two concerns are required. Firstly, the regulatory 
mechanism of protein S-sulfhydration by Trx1 may be commonly occurred in 
various proteins based on redox status of cells since Trx1 is related to control 
redox environment in the cells. Secondly, the possibility of other enzymes, except 
for Trx1, will be considered for further investigation of regulatory mechanism of 
protein S-sulfhydration since GAPDH also mediates protein S-nitrosylation (220).  
 
2. To further investigate the forming mechanism of S-sulfhydration. Unlike 
phosphorylation, the forming mechanism of S-sulfhydration is unclear. The 
relationship among GSSH, glutathione persulfide, and protein S-sulfhydration is 
critical for the regulation of protein S-sulfhydration (162). Acid-base motif is 
considered as a potential forming mechanism of protein S-nitrosylation. RSNO 
derived from NO including GSNO is known as a NO donor for protein S-
nitrosylation. Therefore, GSSH or other persulfides derived from H2S may be 
involved in forming of protein S-sulfhydration, similar to the forming mechanism 




3. To elucidate the relationship between protein S-nitrosylation and S-sulfhydration. 
Methodological approach is important for this study. Up to date, the study for the 
relationship between protein S-nitrosylation and S-sulfhydration was determined 
with comparison of protein S-nitrosylation and S-sulfhydration in separate 
samples (94,178). Development of detection methods for protein S-nitrosylation 
and S-sulfhydration at the same time will be necessary for the further study. 
Protein S-nitrosylation and S-sulfhydration possess an opposite role in GAPDH 
and eNOS (94,178). In addition, protein S-nitrosylation and S-sulfhydration share 
the same cysteine residue in GAPDH and eNOS. Therefore, the balance of protein 
S-nitrosylation and S-sulfhydration in the cells may be involved in the various 
diseases which are related to protein S-nitrosylation and S-sulfhydration, such as 
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